riskAllele,pValue,pValueAnnotation,riskFrequency,orValue,beta,ci,mappedGenes,traitName,efoTraits,bgTraits,accessionId,locations
chr21:46916033-?,7.999999999999999e-240,-,NR,1.719,-,[1.673-1.768],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr3:64699445-?,5.999999999999999e-44,-,NR,1.78,-,[1.707-1.857],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr12:27737074-?,9.999999999999999e-34,-,NR,1.4,-,[1.359-1.442],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr16:29348809-?,4.0000000000000003e-28,-,NR,1.216,-,[1.185-1.247],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr16:79360135-?,3e-27,-,NR,1.1737089,-,[1.15-1.2],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr8:135611154-?,2.9999999999999997e-96,-,NR,1.152,-,[1.127-1.177],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr19:22620820-?,6e-25,-,NR,1.213,-,[1.176-1.253],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr7:111916329-?,2e-16,-,NR,1.151,-,[1.123-1.179],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr5:108436958-?,4e-133,-,NR,1.945,-,[1.734-2.182],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr5:120977240-?,3e-46,-,NR,1.2106538,-,[1.17-1.25],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr9:111929013-?,2e-31,-,NR,1.517,-,[1.375-1.673],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr1:164546863-?,1e-10,-,NR,1.257,-,[1.175-1.346],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
chr9:135955826-?,1e-14,-,NR,2.158,-,[1.777-2.619],-,Early-onset Parkinson's disease,Young adult-onset Parkinsonism,-,GCST004138,-
rs356220-T,3e-8,-,0.35,1.37,-,[NR],SNCA,Parkinson's disease,Parkinson disease,-,GCST000874,4:89720189
rs4698412-A,2e-6,-,0.55,1.14,-,[1.08-1.20],BST1,Parkinson's disease,Parkinson disease,-,GCST000874,4:15735725
rs4964469-A,2e-7,-,0.37,1.16,-,[1.09-1.22],"POLR3B,RFX4",Parkinson's disease,Parkinson disease,-,GCST000874,12:106556209
rs6599388-T,4e-12,-,0.31,1.16,-,[1.12-1.20],TMEM175,Parkinson's disease,Parkinson disease,-,GCST000959,4:945299
rs11724635-A,1e-16,-,0.56,1.15,-,[1.11-1.19],BST1,Parkinson's disease,Parkinson disease,-,GCST000959,4:15735478
rs1491942-G,6e-14,-,0.08,1.27,-,[1.21-1.33],LRRK2,Parkinson's disease,Parkinson disease,-,GCST000959,12:40227006
rs34372695-T,4e-12,-,0.03,1.47,-,[1.35-1.59],"RAB25,LAMTOR2",Parkinson's disease,Parkinson disease,-,GCST000959,1:156060246
rs6710823-G,7e-9,-,0.46,1.1,-,[1.06-1.14],CCNT2-AS1,Parkinson's disease,Parkinson disease,-,GCST000959,2:134834811
rs11711441-G,8e-12,-,0.86,1.19,-,[1.13-1.25],MCCC1,Parkinson's disease,Parkinson disease,-,GCST000959,3:183103487
rs356219-G,2e-47,-,0.39,1.29,-,[1.25-1.33],SNCA,Parkinson's disease,Parkinson disease,-,GCST000959,4:89716450
rs2102808-C,4e-10,-,0.12,1.18,-,[1.12-1.24],"STK39,RN7SL813P",Parkinson's disease,Parkinson disease,-,GCST000959,2:168260515
6:32588205-A,2e-14,-,0.76,1.28,-,[1.22-1.34],-,Parkinson's disease,Parkinson disease,-,GCST000959,-
rs12817488-T,3e-13,-,0.41,1.14,-,[1.10-1.18],CCDC62,Parkinson's disease,Parkinson disease,-,GCST000959,12:122811747
rs2942168-G,1.0000000000000001e-28,-,0.78,1.27,-,[1.23-1.31],"LINC02210,LINC02210-CRHR1",Parkinson's disease,Parkinson disease,-,GCST000959,17:45637484
rs6812193-C,8e-10,-,0.64,1.19,-,[1.12-1.27],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST001126,4:76277833
rs356220-T,2e-19,-,0.375,1.29,-,[1.22-1.36],SNCA,Parkinson's disease,Parkinson disease,-,GCST001126,4:89720189
rs12185268-A,3e-14,-,0.79,1.3,-,[1.22-1.39],"MAPT-AS1,SPPL2C",Parkinson's disease,Parkinson disease,-,GCST001126,17:45846317
rs10513789-T,3e-10,-,0.80,1.25,-,[1.16-1.33],MCCC1,Parkinson's disease,Parkinson disease,-,GCST001126,3:183042285
rs6599389-A,4e-8,-,0.075,1.31,-,[1.19-1.44],TMEM175,Parkinson's disease,Parkinson disease,-,GCST001126,4:945325
rs4130047-C,2e-7,-,0.31,1.16,-,[1.10-1.23],RIT2,Parkinson's disease,Parkinson disease,-,GCST001126,18:43098270
rs11868035-G,6e-8,-,0.69,1.18,-,[1.11-1.25],SREBF1,Parkinson's disease,Parkinson disease,-,GCST001126,17:17811787
rs34637584-A,2.0000000000000002e-28,-,0.002,9.62,-,[6.43-14.37],LRRK2,Parkinson's disease,Parkinson disease,-,GCST001126,12:40340400
i4000416-C,5e-21,-,0.005,4.05,-,[3.08-5.32],-,Parkinson's disease,Parkinson disease,-,GCST001126,-
rs823156-A,1e-7,-,0.82,1.21,-,[1.12-1.30],SLC41A1,Parkinson's disease,Parkinson disease,-,GCST001126,1:205795512
rs2823357-A,6e-7,-,0.38,1.15,-,[1.09-1.21],"CYCSP42,RNU6-1326P",Parkinson's disease,Parkinson disease,-,GCST001126,21:15542586
rs2839398-?,5e-6,-,NR,1.23,-,[NR],PRDM15,Parkinson's disease,Parkinson disease,-,GCST001430,21:41866243
rs356220-?,8e-35,-,NR,1.38,-,[NR],SNCA,Parkinson's disease,Parkinson disease,-,GCST001430,4:89720189
rs9917256-?,3e-6,-,NR,1.19,-,[NR],"RN7SL813P,STK39",Parkinson's disease,Parkinson disease,-,GCST001430,2:168286525
rs4698412-?,3e-7,-,NR,1.14,-,[NR],BST1,Parkinson's disease,Parkinson disease,-,GCST001430,4:15735725
rs2275336-?,9e-7,-,NR,1.36,-,[NR],CNKSR3,Parkinson's disease,Parkinson disease,-,GCST001430,6:154405854
rs2395163-?,3e-11,-,NR,1.24,-,[NR],"TSBP1-AS1,HLA-DRA",Parkinson's disease,Parkinson disease,-,GCST001430,6:32420032
rs12726330-?,5e-8,-,NR,1.71,-,[NR],SLC50A1,Parkinson's disease,Parkinson disease,-,GCST001430,1:155135691
rs6430538-?,2e-7,-,NR,1.15,-,[NR],CCNT2-AS1,Parkinson's disease,Parkinson disease,-,GCST001430,2:134782397
rs11248060-?,3e-9,-,NR,1.26,-,[NR],DGKQ,Parkinson's disease,Parkinson disease,-,GCST001430,4:970571
rs1296028-?,1e-6,-,NR,1.15,-,[NR],"CTSB,FDFT1",Parkinson's disease,Parkinson disease,-,GCST001430,8:11841238
rs1536076-?,5e-7,-,NR,1.16,-,[NR],SH3GL2,Parkinson's disease,Parkinson disease,-,GCST001430,9:17731923
rs11026412-?,3e-6,-,NR,1.16,-,[NR],ANO5,Parkinson's disease,Parkinson disease,-,GCST001430,11:22092547
rs10877840-?,1e-6,-,NR,1.15,-,[NR],SLC2A13,Parkinson's disease,Parkinson disease,-,GCST001430,12:39959194
rs10519131-?,1e-6,-,NR,1.22,-,[NR],"LINC02349,RORA",Parkinson's disease,Parkinson disease,-,GCST001430,15:61708933
rs11865038-?,4e-7,-,NR,1.14,-,[NR],"PRSS53,ZNF646",Parkinson's disease,Parkinson disease,-,GCST001430,16:31083850
rs199515-?,3e-17,-,NR,1.32,-,[NR],WNT3,Parkinson's disease,Parkinson disease,-,GCST001430,17:46779275
rs12456492-?,2e-10,-,NR,1.19,-,[NR],RIT2,Parkinson's disease,Parkinson disease,-,GCST001430,18:43093415
rs1223271-G,5e-6,-,0.87,1.18,-,[NR],"ISM1,TASP1",Parkinson's disease,Parkinson disease,-,GCST000528,20:13316265
rs6812193-C,4e-7,-,0.66,1.12,-,[NR],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST000528,4:76277833
rs7077361-T,5e-6,-,0.89,1.19,-,[NR],ITGA8,Parkinson's disease,Parkinson disease,-,GCST000528,10:15519544
rs2736990-C,2e-16,-,0.51,1.23,-,[NR],SNCA,Parkinson's disease,Parkinson disease,-,GCST000528,4:89757390
rs199533-C,1e-14,-,0.83,1.28,-,[NR],NSF,Parkinson's disease,Parkinson disease,-,GCST000528,17:46751565
rs393152-A,2e-16,-,0.82,1.3,-,[NR],"LINC02210-CRHR1,LINC02210",Parkinson's disease,Parkinson disease,-,GCST000528,17:45641777
rs823128-A,7e-8,-,0.97,1.52,-,[NR],NUCKS1,Parkinson's disease,Parkinson disease,-,GCST000528,1:205744250
rs17115100-G,7e-8,-,0.91,1.25,-,[NR],"CYP17A1,WBP1L",Parkinson's disease,Parkinson disease,-,GCST000528,10:102831636
rs6532197-G,1e-7,-,0.09,1.32,-,[NR],"MMRN1,SNCA-AS1",Parkinson's disease,Parkinson disease,-,GCST000528,4:89876150
rs12431733-T,3e-6,-,0.48,1.13,-,[NR],"LINC02331,DDHD1-DT",Parkinson's disease,Parkinson disease,-,GCST000528,14:53824112
rs356220-T,3e-11,-,0.36,1.38,-,[1.25-1.52],SNCA,Parkinson's disease,Parkinson disease,-,GCST000772,4:89720189
rs11248051-T,3e-9,-,0.09,1.46,-,[1.29-1.65],GAK,Parkinson's disease,Parkinson disease,-,GCST000772,4:864544
rs199533-C,1e-6,-,0.78,1.35,-,[1.19-1.52],NSF,Parkinson's disease,Parkinson disease,-,GCST000772,17:46751565
rs3129882-G,2e-10,-,0.40,1.26,-,[1.17-1.35],HLA-DRA,Parkinson's disease,Parkinson disease,-,GCST000772,6:32441753
rs1480597-?,2e-6,NA,NR,2.5,-,[1.67-3.33],"RPL9P21,TMEM72-AS1",Parkinson's disease,Parkinson disease,-,GCST000005,10:44665661
rs2242330-?,2e-6,NA,NR,2.0,-,[1.43-2.50],STAP1,Parkinson's disease,Parkinson disease,-,GCST000005,4:67581531
rs10501570-?,7e-6,-,NR,5.0,-,[2.00-12.50],DLG2,Parkinson's disease,Parkinson disease,-,GCST000005,11:84706803
rs7702187-?,8e-6,NA,NR,1.74,-,[1.36-2.24],SEMA5A,Parkinson's disease,Parkinson disease,-,GCST000002,5:9332169
rs11931074-?,7e-17,-,NR,1.37,-,[1.27-1.48],SNCA,Parkinson's disease,Parkinson disease,-,GCST000530,4:89718364
rs4538475-?,3e-9,-,NR,1.24,-,[1.16-1.34],BST1,Parkinson's disease,Parkinson disease,-,GCST000530,4:15736314
rs1994090-?,3e-8,-,NR,1.39,-,[1.24-1.56],SLC2A13,Parkinson's disease,Parkinson disease,-,GCST000530,12:40034759
rs947211-?,2e-12,-,NR,1.3,-,[1.21-1.39],"SLC41A1,RAB29",Parkinson's disease,Parkinson disease,-,GCST000530,1:205783537
rs1564282-T,7e-7,-,0.09,1.7,-,[NR],GAK,Parkinson's disease (familial),Parkinson disease,-,GCST000261,4:858525
rs11012-T,6e-8,-,NR,1.43,-,[1.27-1.61],PLEKHM1,Parkinson's disease,Parkinson disease,-,GCST000567,17:45436075
rs12063142-?,5e-7,-,NR,-,-,-,"PAX7,TAS1R2",Parkinson's disease,Parkinson disease,-,GCST000567,1:18813023
rs4837628-A,1e-6,-,NR,1.27,-,[1.15-1.39],BRINP1,Parkinson's disease,Parkinson disease,-,GCST000567,9:119297431
rs11248060-?,2e-6,-,NR,-,-,-,DGKQ,Parkinson's disease,Parkinson disease,-,GCST000567,4:970571
rs10464059-A,3e-6,-,NR,1.33,-,[1.19-1.52],"RNU6-525P,GFPT2",Parkinson's disease,Parkinson disease,-,GCST000567,5:180367208
rs2736990-?,7e-8,-,NR,1.29,-,[1.18-1.43],SNCA,Parkinson's disease,Parkinson disease,-,GCST000567,4:89757390
rs8070723-?,7e-12,-,0.76,1.3,-,[1.19-1.43],MAPT,Parkinson's disease,Parkinson disease,-,GCST000855,17:46003698
rs7617877-A,3e-6,-,0.36,1.23,-,[1.13-1.33],RBMS3,Parkinson's disease,Parkinson disease,-,GCST000855,3:28664273
rs356220-A,9e-16,-,0.36,1.27,-,[1.17-1.37],SNCA,Parkinson's disease,Parkinson disease,-,GCST000855,4:89720189
rs183211-T,3e-7,-,0.24,-,-,-,NSF,Parkinson's disease,Parkinson disease,-,GCST001189,17:46710944
rs10121009-A,3e-6,-,0.21,-,-,-,UNC13B,Parkinson's disease,Parkinson disease,-,GCST001189,9:35269822
rs415430-T,7e-7,-,0.786,-,-,-,WNT3,Parkinson's disease,Parkinson disease,-,GCST001189,17:46781778
rs7118648-G,2e-7,-,0.03,-,-,-,CCDC82,Parkinson's disease,Parkinson disease,-,GCST002077,11:96375264
rs3935740-T,2e-7,-,0.08,-,-,-,"TMC3-AS1,TMC3",Parkinson's disease,Parkinson disease,-,GCST002077,15:81334384
rs17497526-G,6e-7,-,0.15,-,-,-,COL13A1,Parkinson's disease,Parkinson disease,-,GCST002077,10:69820364
rs10958605-?,2e-6,(motor outcome),NR,1.81,-,[1.42-2.31],"SIRLNT,LINC02866",Parkinson's disease (motor and cognition),Parkinson disease,-,GCST001546,8:40196086
rs959573-?,5e-6,(cognitive outcome),NR,1.92,-,[1.49-2.50],"LMNB1,MARCHF3",Parkinson's disease (motor and cognition),Parkinson disease,-,GCST001546,5:126846170
rs6482992-?,4e-6,(congnitive outcome),NR,2.03,-,[1.47-2.79],CLRN3,Parkinson's disease (motor and cognition),Parkinson disease,-,GCST001546,10:127880410
rs17000647-?,5e-6,(cognitive outcome),NR,5.58,-,[3.00-10.38],ODAPH,Parkinson's disease (motor and cognition),Parkinson disease,-,GCST001546,4:75556520
rs3027247-?,9e-6,(cognitive outcome),NR,1.89,-,[1.41-2.50],CTC1,Parkinson's disease (motor and cognition),Parkinson disease,-,GCST001546,17:8227549
rs34778348-?,3e-21,(Asian),0.04,2.23,-,[1.89-2.63],LRRK2,Parkinson's disease,Parkinson disease,-,GCST001445,12:40363526
rs1491942-?,6e-15,(EA),0.21,1.17,-,[1.13-1.22],LRRK2,Parkinson's disease,Parkinson disease,-,GCST001445,12:40227006
rs11248060-?,3e-12,(EA),0.12,1.21,-,[1.15-1.27],DGKQ,Parkinson's disease,Parkinson disease,-,GCST001445,4:970571
H1H2-?,8e-52,(EA),0.80,1.28,-,[1.25-1.33],-,Parkinson's disease,Parkinson disease,-,GCST001445,-
rs356219-?,6e-65,(EA),0.41,1.29,-,[1.25-1.33],SNCA,Parkinson's disease,Parkinson disease,-,GCST001445,4:89716450
rs6532194-?,5e-11,(Asian),0.40,1.29,-,[1.20-1.39],"MMRN1,SNCA-AS1",Parkinson's disease,Parkinson disease,-,GCST001445,4:89859751
rs2338971-C,4e-10,(Sporadic),0.773,1.35,-,[1.27-1.43],"LINC01307,LINC01709",Parkinson's disease,Parkinson disease,-,GCST002353,1:101414449
rs356220-T,1e-9,(Sporadic),0.364,1.37,-,[1.23-1.51],SNCA,Parkinson's disease,Parkinson disease,-,GCST002353,4:89720189
rs356220-T,3e-11,-,0.364,1.38,-,[1.24-1.52],SNCA,Parkinson's disease,Parkinson disease,-,GCST002353,4:89720189
rs3129882-G,3e-8,-,0.395,1.31,-,[1.19-1.43],HLA-DRA,Parkinson's disease,Parkinson disease,-,GCST002353,6:32441753
rs3129882-G,5e-10,(Sporadic),0.395,1.38,-,[1.24-1.52],HLA-DRA,Parkinson's disease,Parkinson disease,-,GCST002353,6:32441753
rs199498-T,2e-6,-,0.764,1.35,-,[1.25-1.45],WNT3,Parkinson's disease,Parkinson disease,-,GCST002353,17:46788237
rs199498-T,8e-7,(Familial),0.764,1.69,-,[1.57-1.81],WNT3,Parkinson's disease,Parkinson disease,-,GCST002353,17:46788237
rs2338971-C,5e-10,-,0.773,1.32,-,[1.26-1.38],"LINC01307,LINC01709",Parkinson's disease,Parkinson disease,-,GCST002353,1:101414449
rs11158026-C,6e-11,-,0.665,1.11,-,[1.08-1.14],GCH1,Parkinson's disease,Parkinson disease,-,GCST002544,14:54882151
rs1555399-T,7e-14,-,0.532,1.1148,-,[1.09-1.14],TMEM229B,Parkinson's disease,Parkinson disease,-,GCST002544,14:67517653
rs2414739-A,1e-11,-,0.734,1.113,-,[1.08-1.14],"LINC02349,RORA",Parkinson's disease,Parkinson disease,-,GCST002544,15:61701935
rs14235-A,2e-12,-,0.381,1.103,-,[1.08-1.13],BCKDK,Parkinson's disease,Parkinson disease,-,GCST002544,16:31110472
rs17649553-C,2e-48,-,0.774,1.3,-,[1.27-1.34],MAPT,Parkinson's disease,Parkinson disease,-,GCST002544,17:45917282
rs12456492-G,8e-12,-,0.307,1.11,-,[1.08-1.14],RIT2,Parkinson's disease,Parkinson disease,-,GCST002544,18:43093415
rs62120679-T,6e-7,-,0.314,1.097,-,[1.06-1.13],TMPRSS9,Parkinson's disease,Parkinson disease,-,GCST002544,19:2363321
rs8118008-A,3e-11,-,0.657,1.111,-,[1.08-1.14],"DDRGK1,LZTS3",Parkinson's disease,Parkinson disease,-,GCST002544,20:3187520
rs591323-G,7e-8,-,0.725,1.09,-,[1.06-1.12],"RN7SL474P,MSR1",Parkinson's disease,Parkinson disease,-,GCST002544,8:16839582
rs35749011-A,1.0000000000000001e-29,-,0.017,1.824,-,[1.72-1.93],"KRTCAP2,HMGN2P18",Parkinson's disease,Parkinson disease,-,GCST002544,1:155162560
rs823118-T,2e-16,-,0.559,1.122,-,[1.09-1.15],"NUCKS1,RAB29",Parkinson's disease,Parkinson disease,-,GCST002544,1:205754444
rs10797576-T,5e-10,-,0.14,1.131,-,[1.09-1.17],SIPA1L2,Parkinson's disease,Parkinson disease,-,GCST002544,1:232528865
rs6430538-C,9e-20,-,0.57,1.1429,-,[1.11-1.17],CCNT2-AS1,Parkinson's disease,Parkinson disease,-,GCST002544,2:134782397
rs1474055-T,1e-20,-,0.128,1.214,-,[1.17-1.26],"STK39,RN7SL813P",Parkinson's disease,Parkinson disease,-,GCST002544,2:168253884
rs12637471-G,2e-21,-,0.807,1.1876,-,[1.15-1.22],MCCC1,Parkinson's disease,Parkinson disease,-,GCST002544,3:183044649
rs34311866-C,1e-43,-,0.191,1.27,-,[1.24-1.30],TMEM175,Parkinson's disease,Parkinson disease,-,GCST002544,4:958159
rs11724635-A,9e-18,-,0.553,1.126,-,[1.1-1.15],BST1,Parkinson's disease,Parkinson disease,-,GCST002544,4:15735478
rs6812193-C,3e-11,-,0.636,1.1,-,[1.07-1.13],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST002544,4:76277833
rs356182-G,4e-73,-,0.367,1.32,-,[1.29-1.35],SNCA,Parkinson's disease,Parkinson disease,-,GCST002544,4:89704960
rs9275326-C,1e-12,-,0.906,1.21,-,[1.16-1.26],"HLA-DQB1,MTCO3P1",Parkinson's disease,Parkinson disease,-,GCST002544,6:32698883
rs199347-A,1e-12,-,0.59,1.11,-,[1.08-1.14],GPNMB,Parkinson's disease,Parkinson disease,-,GCST002544,7:23254127
rs117896735-A,4e-13,-,0.014,1.624,-,[1.49-1.76],INPP5F,Parkinson's disease,Parkinson disease,-,GCST002544,10:119776815
rs3793947-G,4e-7,-,0.557,1.0764,-,[1.05-1.11],DLG2,Parkinson's disease,Parkinson disease,-,GCST002544,11:83833429
rs329648-T,1e-11,-,0.354,1.105,-,[1.08-1.13],"IGSF9B,SPATA19",Parkinson's disease,Parkinson disease,-,GCST002544,11:133895472
rs76904798-T,5e-14,-,0.143,1.155,-,[1.12-1.19],"LRRK2-DT,LRRK2",Parkinson's disease,Parkinson disease,-,GCST002544,12:40220632
rs11060180-A,6e-12,-,0.558,1.105,-,[1.08-1.13],CCDC62,Parkinson's disease,Parkinson disease,-,GCST002544,12:122819039
rs1442190-?,2e-27,-,0.0264,3.72,-,[2.98-4.64],CNTN1,Parkinson's disease,Parkinson disease,-,GCST002455,12:40971838
rs17577094-?,8e-9,-,0.74,1.56,-,[1.39-1.79],KANSL1,Parkinson's disease,Parkinson disease,-,GCST002455,17:46110126
rs1630500-?,2e-8,-,0.045,1.75,-,[1.43-2.15],"KCNN3,PMVK",Parkinson's disease,Parkinson disease,-,GCST002455,1:154882579
rs823114-?,3e-6,-,0.59,1.33,-,[1.20-1.47],"NUCKS1,RAB29",Parkinson's disease,Parkinson disease,-,GCST002455,1:205750404
kgp8090149-?,1e-6,-,NR,4.95,-,[3.50-7.00],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs849898-?,1e-6,-,NR,2.73,-,[1.96-3.79],"CICP26,WNT9A",Parkinson's disease,Parkinson disease,-,GCST003059,1:227966216
kgp7172368-?,1e-6,-,NR,2.63,-,[1.91-3.63],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp11353523-?,1e-6,-,NR,2.7777777,-,[2.00-3.85],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs11186-?,1e-6,-,NR,2.79,-,[1.94-4.03],COL5A2,Parkinson's disease,Parkinson disease,-,GCST003059,2:189032668
kgp760898-?,1e-6,-,NR,3.97,-,[2.82-5.60],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs6783485-?,1e-6,-,NR,5.0,-,[2.86-8.33],CFAP20DC-DT,Parkinson's disease,Parkinson disease,-,GCST003059,3:59442071
rs1879553-?,1e-6,-,NR,2.83,-,[1.98-4.04],"IGSF11,LSAMP",Parkinson's disease,Parkinson disease,-,GCST003059,3:118896616
kgp9482779-?,1e-6,-,NR,5.5555553,-,[4.00-8.33],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs13153459-?,1e-6,-,NR,2.45,-,[1.79-3.34],MRPS30-DT,Parkinson's disease,Parkinson disease,-,GCST003059,5:44515833
kgp154172-?,1e-6,-,NR,8.2,-,[5.70-11.78],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp8130520-?,1e-6,-,NR,3.72,-,[2.75-5.04],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp4105983-?,1e-6,-,NR,3.448276,-,[2.33-5.00],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs10746953-?,1e-6,-,NR,2.62,-,[1.91-3.60],RORB-AS1,Parkinson's disease,Parkinson disease,-,GCST003059,9:74302924
kgp10769919-?,1e-6,-,NR,3.448276,-,[2.27-5.26],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp6542803-?,1e-6,-,NR,2.29,-,[1.72-3.06],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp9550589-?,1e-6,-,NR,2.37,-,[1.78-3.14],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs9323124-?,1e-6,-,NR,3.97,-,[2.91-5.42],"MDGA2,RPA2P1",Parkinson's disease,Parkinson disease,-,GCST003059,14:46996974
kgp11333367-?,1e-6,-,NR,4.3,-,[3.16-5.85],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
kgp348599-?,1e-6,-,NR,2.85,-,[2.13-3.82],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs1362858-?,1e-6,-,NR,2.68,-,[1.92-3.73],"ZNF24TR,RPL7AP67",Parkinson's disease,Parkinson disease,-,GCST003059,18:35406636
kgp4156164-?,1e-6,-,NR,6.59,-,[4.25-10.20],-,Parkinson's disease,Parkinson disease,-,GCST003059,-
rs356182-?,4e-11,-,NR,-,-,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST90320240,4:89704960
rs59330234-?,1e-8,-,NR,-,-,-,CCDC85A,Parkinson's disease,Parkinson disease,-,GCST90320240,2:56375408
rs2270968-G,3e-8,-,0.338,1.178,-,NR,MCCC1,Parkinson's disease,Parkinson disease,-,GCST003922,3:183037421
rs8180209-?,9.999999999999999e-33,-,NR,1.41,-,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST003922,4:89723303
rs1384236-C,8e-12,-,0.035,1.551,-,NR,SLC2A13,Parkinson's disease,Parkinson disease,-,GCST003922,12:40064582
rs7479949-?,6e-8,-,NR,1.16,-,-,DLG2,Parkinson's disease,Parkinson disease,-,GCST003922,11:83792361
rs28903073-?,1e-39,-,NR,3.1152647,-,[2.68-3.62],LRRK2,Parkinson's disease,Parkinson disease,-,GCST003984,12:40259708
rs144847051-?,4e-21,-,NR,2.2371366,-,[1.92-2.61],"ASS1P14,SYT10",Parkinson's disease,Parkinson disease,-,GCST003984,12:33148871
rs13016703-?,3e-16,-,NR,1.2091899,-,[1.16-1.26],"STK39,RN7SL813P",Parkinson's disease,Parkinson disease,-,GCST003984,2:168299085
rs35541465-?,3e-15,-,NR,1.1560693,-,[1.12-1.20],GAK,Parkinson's disease,Parkinson disease,-,GCST003984,4:879499
rs11158026-?,9e-15,-,NR,1.1454753,-,[1.11-1.18],GCH1,Parkinson's disease,Parkinson disease,-,GCST003984,14:54882151
rs9858038-?,3e-14,-,NR,1.172,-,[1.124-1.221],"DCUN1D1,MCCC1",Parkinson's disease,Parkinson disease,-,GCST003984,3:183012503
rs10256359-?,2e-12,-,NR,1.1273957,-,[1.09-1.17],"HYCC1,KLHL7-DT",Parkinson's disease,Parkinson disease,-,GCST003984,7:23084258
rs188789342-?,3e-11,-,NR,1.488,-,[1.331-1.663],"TIAL1,RAD1P1",Parkinson's disease,Parkinson disease,-,GCST003984,10:119612816
rs6812193-?,7e-11,-,NR,1.1148272,-,[1.08-1.15],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST003984,4:76277833
rs4266290-?,8e-11,-,NR,1.128,-,[1.088-1.171],BST1,Parkinson's disease,Parkinson disease,-,GCST003984,4:15735495
rs4130047-?,2e-10,-,NR,1.1148272,-,[1.08-1.15],RIT2,Parkinson's disease,Parkinson disease,-,GCST003984,18:43098270
rs11060180-?,3e-10,-,NR,1.1074197,-,[1.07-1.14],CCDC62,Parkinson's disease,Parkinson disease,-,GCST003984,12:122819039
rs148294058-?,5e-9,-,NR,1.5698587,-,[1.36-1.81],LINC02450,Parkinson's disease,Parkinson disease,-,GCST003984,12:42655580
rs2209440-?,8e-9,-,NR,1.0964912,-,[1.06-1.13],SH3GL2,Parkinson's disease,Parkinson disease,-,GCST003984,9:17736344
rs11343-?,1e-8,-,NR,1.096,-,[1.062-1.131],SYT17,Parkinson's disease,Parkinson disease,-,GCST003984,16:19268142
rs162227-?,1e-8,-,NR,1.1627907,-,[1.10-1.22],NDUFAF2,Parkinson's disease,Parkinson disease,-,GCST003984,5:60964716
rs144074972-?,6e-8,-,NR,-,-,-,CA8,Parkinson's disease,Parkinson disease,-,GCST003984,8:60251336
rs601999-?,7e-8,-,NR,1.095,-,[1.060-1.132],"NAGLU,HSD17B1P1",Parkinson's disease,Parkinson disease,-,GCST003984,17:42546140
rs356182-?,9.999999999999999e-57,-,NR,1.318,-,[1.274-1.363],SNCA,Parkinson's disease,Parkinson disease,-,GCST003984,4:89704960
rs365825-?,3.9999999999999997e-32,-,NR,1.2722646,-,[1.22-1.33],"LINC02210,LINC02210-CRHR1",Parkinson's disease,Parkinson disease,-,GCST003984,17:45628235
rs17425622-?,4e-17,-,NR,1.235,-,[1.174-1.298],"HLA-DQA1,HLA-DRB1",Parkinson's disease,Parkinson disease,-,GCST003984,6:32604184
rs2230288-?,5e-17,-,NR,1.674,-,[1.495-1.873],GBA1,Parkinson's disease,Parkinson disease,-,GCST003984,1:155236376
rs823118-?,6e-12,-,NR,1.117,-,[1.082-1.153],"NUCKS1,RAB29",Parkinson's disease,Parkinson disease,-,GCST003984,1:205754444
rs4713118-?,2e-10,-,NR,1.121,-,[1.083-1.162],LINC01012,Parkinson's disease,Parkinson disease,-,GCST003984,6:27709015
rs687432-?,2e-9,-,NR,1.113,-,[1.075-1.153],"OR5AZ1P,OR5BD1P",Parkinson's disease,Parkinson disease,-,GCST003984,11:57926788
rs13294100-G,5e-13,-,0.629,1.0869565,-,[1.06-1.12],SH3GL2,Parkinson's disease,Parkinson disease,-,GCST004902,9:17579692
rs10906923-A,1e-8,-,0.694,1.0752687,-,[1.04-1.1],ITGA8,Parkinson's disease,Parkinson disease,-,GCST004902,10:15527599
rs8005172-T,9e-11,-,0.424,1.08,-,[1.05-1.10],GPR65,Parkinson's disease,Parkinson disease,-,GCST004902,14:88006268
rs11343-T,9e-11,-,0.454,1.07,-,[1.05-1.10],SYT17,Parkinson's disease,Parkinson disease,-,GCST004902,16:19268142
rs4784227-T,1e-10,-,0.265,1.09,-,[1.06-1.12],CASC16,Parkinson's disease,Parkinson disease,-,GCST004902,16:52565276
rs10929159-A,7e-8,-,NR,1.0626993,-,-,AGAP1,Parkinson's disease,Parkinson disease,-,GCST004902,2:236024319
rs117896735-A,2e-19,-,0.015,1.65,-,[1.48-1.85],INPP5F,Parkinson's disease,Parkinson disease,-,GCST004902,10:119776815
rs3793947-G,4e-9,-,0.558,1.0752687,-,[1.05-1.1],DLG2,Parkinson's disease,Parkinson disease,-,GCST004902,11:83833429
rs329648-T,1e-13,-,0.351,1.09,-,[1.07-1.12],"IGSF9B,SPATA19",Parkinson's disease,Parkinson disease,-,GCST004902,11:133895472
rs76904798-T,1e-19,-,0.137,1.15,-,[1.12-1.19],"LRRK2-DT,LRRK2",Parkinson's disease,Parkinson disease,-,GCST004902,12:40220632
rs11060180-A,2e-20,-,0.551,1.1111112,-,[1.09-1.14],CCDC62,Parkinson's disease,Parkinson disease,-,GCST004902,12:122819039
rs11158026-C,4e-16,-,0.669,1.098901,-,[1.08-1.12],GCH1,Parkinson's disease,Parkinson disease,-,GCST004902,14:54882151
rs1555399-T,1e-10,-,0.514,1.09,-,[1.06-1.11],TMEM229B,Parkinson's disease,Parkinson disease,-,GCST004902,14:67517653
rs2414739-A,4e-14,-,0.734,1.098901,-,[1.08-1.12],"LINC02349,RORA",Parkinson's disease,Parkinson disease,-,GCST004902,15:61701935
rs316619-C,7e-6,-,NR,1.0548522,-,[1.03-1.08],LTK,Parkinson's disease,Parkinson disease,-,GCST004902,15:41506416
rs5910-C,4e-6,-,NR,1.056,-,[1.03-1.08],ITGA2B,Parkinson's disease,Parkinson disease,-,GCST004902,17:44372421
rs62120679-T,7e-7,-,0.31,1.08,-,[1.05-1.11],TMPRSS9,Parkinson's disease,Parkinson disease,-,GCST004902,19:2363321
rs8118008-A,2e-6,-,0.609,1.07,-,[1.04-1.09],"DDRGK1,LZTS3",Parkinson's disease,Parkinson disease,-,GCST004902,20:3187520
rs4653767-T,2e-11,-,0.685,1.0869565,-,[1.06-1.11],ITPKB,Parkinson's disease,Parkinson disease,-,GCST004902,1:226728377
rs34043159-C,5e-11,-,0.352,1.08,-,[1.06-1.10],MAP4K4,Parkinson's disease,Parkinson disease,-,GCST004902,2:101796654
rs823118-T,1.0000000000000001e-23,-,0.557,1.1235955,-,[1.1-1.15],"NUCKS1,RAB29",Parkinson's disease,Parkinson disease,-,GCST004902,1:205754444
rs4073221-G,2e-8,-,0.132,1.1,-,[1.06-1.13],TBC1D5,Parkinson's disease,Parkinson disease,-,GCST004902,3:18235996
rs12497850-T,9e-9,-,0.653,1.0752687,-,[1.04-1.1],IP6K2,Parkinson's disease,Parkinson disease,-,GCST004902,3:48711556
rs143918452-A,3e-8,-,0.004,1.4705882,-,[1.28-1.67],ITIH1,Parkinson's disease,Parkinson disease,-,GCST004902,3:52782824
rs78738012-C,5e-11,-,0.106,1.13,-,[1.09-1.17],CAMK2D,Parkinson's disease,Parkinson disease,-,GCST004902,4:113439216
rs2694528-C,5e-15,-,0.115,1.15,-,[1.11-1.20],NDUFAF2,Parkinson's disease,Parkinson disease,-,GCST004902,5:60978096
rs9468199-A,1e-12,-,0.172,1.11,-,[1.08-1.14],LINC01012,Parkinson's disease,Parkinson disease,-,GCST004902,6:27713436
rs2740594-A,6e-12,-,0.753,1.09,-,[1.07-1.12],CTSB,Parkinson's disease,Parkinson disease,-,GCST004902,8:11849665
rs11724635-A,1e-19,-,0.548,1.1111112,-,[1.09-1.14],BST1,Parkinson's disease,Parkinson disease,-,GCST004902,4:15735478
rs6812193-C,1e-14,-,0.63,1.0869565,-,[1.06-1.11],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST004902,4:76277833
rs356182-G,4.9999999999999996e-123,-,0.349,1.33,-,[1.30-1.36],SNCA,Parkinson's disease,Parkinson disease,-,GCST004902,4:89704960
rs9275326-C,1e-13,-,0.895,1.1764705,-,[1.12-1.22],"HLA-DQB1,MTCO3P1",Parkinson's disease,Parkinson disease,-,GCST004902,6:32698883
rs199347-A,4e-18,-,0.588,1.098901,-,[1.08-1.12],GPNMB,Parkinson's disease,Parkinson disease,-,GCST004902,7:23254127
rs591323-G,2e-11,-,0.726,1.098901,-,[1.06-1.12],"RN7SL474P,MSR1",Parkinson's disease,Parkinson disease,-,GCST004902,8:16839582
rs67460515-C,1e-6,-,NR,1.059,-,[1.04-1.08],SPTSSB,Parkinson's disease,Parkinson disease,-,GCST004902,3:161350778
rs10463554-T,2e-7,-,NR,1.0649627,-,[1.04-1.09],PAM,Parkinson's disease,Parkinson disease,-,GCST004902,5:102983270
rs17767294-G,2e-7,-,NR,1.107,-,[1.07-1.15],"ZNF165,ZSCAN16-AS1",Parkinson's disease,Parkinson disease,-,GCST004902,6:28086420
rs943437-A,6e-8,-,NR,1.0940919,-,[1.06-1.13],"CCN6,LINC02527",Parkinson's disease,Parkinson disease,-,GCST004902,6:111921050
rs2921073-C,1e-7,-,NR,1.0615711,-,[1.04-1.08],LINC02950,Parkinson's disease,Parkinson disease,-,GCST004902,8:8450133
rs2296887-C,2e-7,-,NR,1.084,-,[1.05-1.11],GBF1,Parkinson's disease,Parkinson disease,-,GCST004902,10:102245653
rs9568188-T,4e-7,-,NR,1.0683761,-,[1.04-1.09],CAB39L,Parkinson's disease,Parkinson disease,-,GCST004902,13:49353596
rs9516970-A,5e-7,-,NR,1.065,-,[1.04-1.09],"RPL7AP61,PSMA6P4",Parkinson's disease,Parkinson disease,-,GCST004902,13:97592635
rs8017172-G,2e-7,-,NR,1.0615711,-,[1.04-1.08],"RPL13AP3,KTN1",Parkinson's disease,Parkinson disease,-,GCST004902,14:55732330
rs14235-A,5e-12,-,0.378,1.08,-,[1.06-1.10],BCKDK,Parkinson's disease,Parkinson disease,-,GCST004902,16:31110472
rs17649553-C,9.999999999999999e-69,-,0.779,1.2820514,-,[1.25-1.32],MAPT,Parkinson's disease,Parkinson disease,-,GCST004902,17:45917282
rs12456492-G,6e-16,-,0.315,1.1,-,[1.07-1.12],RIT2,Parkinson's disease,Parkinson disease,-,GCST004902,18:43093415
rs6416935-G,4e-7,-,NR,1.081081,-,[1.05-1.11],"MED13,Y_RNA",Parkinson's disease,Parkinson disease,-,GCST004902,17:62107553
rs35749011-A,3e-35,-,0.012,1.724138,-,[1.59-1.89],"KRTCAP2,HMGN2P18",Parkinson's disease,Parkinson disease,-,GCST004902,1:155162560
rs353116-C,3e-8,-,0.615,1.0638298,-,[1.04-1.09],SCN2A,Parkinson's disease,Parkinson disease,-,GCST004902,2:165277122
rs10797576-T,8e-13,-,0.135,1.12,-,[1.09-1.15],SIPA1L2,Parkinson's disease,Parkinson disease,-,GCST004902,1:232528865
rs6430538-C,8.000000000000001e-24,-,0.55,1.1235955,-,[1.1-1.15],CCNT2-AS1,Parkinson's disease,Parkinson disease,-,GCST004902,2:134782397
rs1474055-T,6e-26,-,0.126,1.2048193,-,[1.16-1.25],"STK39,RN7SL813P",Parkinson's disease,Parkinson disease,-,GCST004902,2:168253884
rs12637471-G,1.9999999999999998e-30,-,0.802,1.1764705,-,[1.15-1.22],MCCC1,Parkinson's disease,Parkinson disease,-,GCST004902,3:183044649
rs34311866-C,9.999999999999999e-51,-,0.184,1.23,-,[1.20-1.27],TMEM175,Parkinson's disease,Parkinson disease,-,GCST004902,4:958159
rs2280104-T,3e-8,-,0.367,1.07,-,[1.04-1.09],BIN3,Parkinson's disease,Parkinson disease,-,GCST004902,8:22668467
rs3104776-A,4e-12,-,NR,-,-,-,CASC16,Parkinson's disease,Parkinson disease,-,GCST90308590,16:52597550
rs113487377-A,1e-8,-,NR,-,-,-,"PHB1P21,CASC16",Parkinson's disease,Parkinson disease,-,GCST90308590,16:52922415
rs11650438-A,1e-7,-,NR,-,-,-,PIGL,Parkinson's disease,Parkinson disease,-,GCST90308590,17:16330946
rs665268-A,2e-7,-,NR,-,-,-,MLX,Parkinson's disease,Parkinson disease,-,GCST90308590,17:42570011
rs62066707-A,9e-11,-,NR,-,-,-,FMNL1-DT,Parkinson's disease,Parkinson disease,-,GCST90308590,17:45196625
rs62053943-T,1e-69,-,NR,-,-,-,LINC02210-CRHR1,Parkinson's disease,Parkinson disease,-,GCST90308590,17:45666837
rs7225082-T,6e-16,-,NR,-,-,-,LINC02210-CRHR1,Parkinson's disease,Parkinson disease,-,GCST90308590,17:45771129
rs34724124-A,7e-8,-,NR,-,-,-,WNT3,Parkinson's disease,Parkinson disease,-,GCST90308590,17:46825150
rs148528915-T,5e-10,(random effect),NR,-,-,-,MED13,Parkinson's disease,Parkinson disease,-,GCST90308590,17:62048221
rs77483524-A,3e-7,-,NR,-,-,-,PGS1,Parkinson's disease,Parkinson disease,-,GCST90308590,17:78408199
rs4485435-C,3e-9,(random effect),NR,-,-,-,FASN,Parkinson's disease,Parkinson disease,-,GCST90308590,17:82087210
rs4588066-A,2.0000000000000002e-28,-,NR,-,-,-,RIT2,Parkinson's disease,Parkinson disease,-,GCST90308590,18:43092999
rs75344947-T,9e-10,(random effect),NR,-,-,-,"SYT4,RNA5SP455",Parkinson's disease,Parkinson disease,-,GCST90308590,18:43360967
rs4815573-T,6e-11,(random effect),NR,-,-,-,"LZTS3,DDRGK1",Parkinson's disease,Parkinson disease,-,GCST90308590,20:3186025
rs73174657-A,5e-7,-,NR,-,-,-,"Y_RNA,RBX1",Parkinson's disease,Parkinson disease,-,GCST90308590,22:41038154
rs10775809-A,6e-8,-,NR,-,-,-,PPP6R2,Parkinson's disease,Parkinson disease,-,GCST90308590,22:50369588
rs12734374-A,3.9999999999999994e-68,-,NR,-,-,-,ASH1L,Parkinson's disease,Parkinson disease,-,GCST90308590,1:155419060
rs10903-A,2e-9,-,NR,-,-,-,VAMP4,Parkinson's disease,Parkinson disease,-,GCST90308590,1:171704096
rs12118655-A,1.9999999999999998e-32,-,NR,-,-,-,"Metazoa_SRP,NUCKS1",Parkinson's disease,Parkinson disease,-,GCST90308590,1:205694350
rs4653767-T,3e-24,-,NR,-,-,-,ITPKB,Parkinson's disease,Parkinson disease,-,GCST90308590,1:226728377
rs1326293-T,1e-17,-,NR,-,-,-,SIPA1L2,Parkinson's disease,Parkinson disease,-,GCST90308590,1:232533936
rs11683001-A,2e-12,-,NR,-,-,-,MAP4K4,Parkinson's disease,Parkinson disease,-,GCST90308590,2:101780501
rs57891859-A,5e-12,-,NR,-,-,-,TMEM163,Parkinson's disease,Parkinson disease,-,GCST90308590,2:134707046
rs12987123-A,3.9999999999999995e-42,-,NR,-,-,-,"RN7SL813P,STK39",Parkinson's disease,Parkinson disease,-,GCST90308590,2:168264031
rs6808178-T,6e-12,-,NR,-,-,-,RBMS3,Parkinson's disease,Parkinson disease,-,GCST90308590,3:28664199
rs12497850-T,3e-9,-,NR,-,-,-,IP6K2,Parkinson's disease,Parkinson disease,-,GCST90308590,3:48711556
rs6803771-A,5e-11,-,NR,-,-,-,MED12L,Parkinson's disease,Parkinson disease,-,GCST90308590,3:151395180
rs7636454-A,3e-9,-,NR,-,-,-,PIK3CA,Parkinson's disease,Parkinson disease,-,GCST90308590,3:179225280
rs11729193-A,2e-11,-,NR,-,-,-,PCGF3,Parkinson's disease,Parkinson disease,-,GCST90308590,4:740563
rs75072999-A,4e-19,-,NR,-,-,-,GAK,Parkinson's disease,Parkinson disease,-,GCST90308590,4:850993
rs34311866-T,5.000000000000001e-75,-,NR,-,-,-,TMEM175,Parkinson's disease,Parkinson disease,-,GCST90308590,4:958159
rs11941559-C,5e-10,-,NR,-,-,-,CC2D2A,Parkinson's disease,Parkinson disease,-,GCST90308590,4:15564251
rs7673321-A,8e-11,-,NR,-,-,-,LCORL,Parkinson's disease,Parkinson disease,-,GCST90308590,4:17956065
rs6854006-T,2e-19,-,NR,-,-,-,"FAM47E-STBD1,FAM47E",Parkinson's disease,Parkinson disease,-,GCST90308590,4:76276901
rs356182-A,3.999999999999999e-170,-,NR,-,-,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST90308590,4:89704960
rs1372518-A,2e-79,-,NR,-,-,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST90308590,4:89836143
rs79214011-A,1e-16,-,NR,-,-,-,MMRN1,Parkinson's disease,Parkinson disease,-,GCST90308590,4:89938128
rs75541595-A,3e-24,-,NR,-,-,-,CCSER1,Parkinson's disease,Parkinson disease,-,GCST90308590,4:90290373
rs1867598-A,7e-22,-,NR,-,-,-,ELOVL7,Parkinson's disease,Parkinson disease,-,GCST90308590,5:60842132
rs246815-C,3e-12,-,NR,-,-,-,"SV2C,SV2C-AS2",Parkinson's disease,Parkinson disease,-,GCST90308590,5:76303351
rs9461359-T,2e-9,-,NR,-,-,-,"VN1R10P,ZNF204P",Parkinson's disease,Parkinson disease,-,GCST90308590,6:27331788
rs9468199-A,9e-13,-,NR,-,-,-,LINC01012,Parkinson's disease,Parkinson disease,-,GCST90308590,6:27713436
rs12528068-T,7e-12,-,NR,-,-,-,"RNU4-66P,RIMS1",Parkinson's disease,Parkinson disease,-,GCST90308590,6:71778059
rs9487736-A,4e-15,-,NR,-,-,-,FYN,Parkinson's disease,Parkinson disease,-,GCST90308590,6:111847106
rs41286192-A,3e-11,-,NR,-,-,-,SLC18B1,Parkinson's disease,Parkinson disease,-,GCST90308590,6:132797077
rs34096562-T,6e-17,-,NR,-,-,-,"RN7SL474P,MSR1",Parkinson's disease,Parkinson disease,-,GCST90308590,8:16843772
rs11783129-A,6e-11,-,NR,-,-,-,PDLIM2,Parkinson's disease,Parkinson disease,-,GCST90308590,8:22595913
rs13294100-T,8e-21,-,NR,-,-,-,SH3GL2,Parkinson's disease,Parkinson disease,-,GCST90308590,9:17579692
rs13664-T,1e-12,-,NR,-,-,-,ITGA8,Parkinson's disease,Parkinson disease,-,GCST90308590,10:15514323
rs2178923-A,2e-13,-,NR,-,-,-,"TXNP1,INPP5F",Parkinson's disease,Parkinson disease,-,GCST90308590,10:119699575
rs4910150-T,1e-11,-,NR,-,-,-,"RNF141,MIR4485",Parkinson's disease,Parkinson disease,-,GCST90308590,11:10511626
rs6592142-T,5e-12,-,NR,-,-,-,DLG2,Parkinson's disease,Parkinson disease,-,GCST90308590,11:83798730
rs3802920-T,9e-20,-,NR,-,-,-,IGSF9B,Parkinson's disease,Parkinson disease,-,GCST90308590,11:133917106
rs73273590-A,9e-17,-,NR,-,-,-,CNTN1,Parkinson's disease,Parkinson disease,-,GCST90308590,12:40861076
rs34773022-A,2e-9,-,NR,-,-,-,"KNTC1,HCAR2",Parkinson's disease,Parkinson disease,-,GCST90308590,12:122638867
rs10847864-T,2e-41,-,NR,-,-,-,HIP1R,Parkinson's disease,Parkinson disease,-,GCST90308590,12:122842051
rs1078514-T,2e-9,-,NR,-,-,-,"IRS2,RN7SKP10",Parkinson's disease,Parkinson disease,-,GCST90308590,13:109810821
rs1956438-A,2e-9,-,NR,-,-,-,MIPOL1,Parkinson's disease,Parkinson disease,-,GCST90308590,14:37539010
rs11158026-T,3e-16,-,NR,-,-,-,GCH1,Parkinson's disease,Parkinson disease,-,GCST90308590,14:54882151
rs1561758-C,9e-10,-,NR,-,-,-,LINC01147,Parkinson's disease,Parkinson disease,-,GCST90308590,14:88021226
rs1870293-T,4.0000000000000004e-24,-,NR,-,-,-,SETD1A,Parkinson's disease,Parkinson disease,-,GCST90308590,16:30959620
rs850731-T,7e-10,-,NR,-,-,-,ITGA2B,Parkinson's disease,Parkinson disease,-,GCST90308590,17:44376902
rs8327-A,4e-11,-,NR,-,-,-,ARHGAP27,Parkinson's disease,Parkinson disease,-,GCST90308590,17:45395141
rs713522-T,1e-38,-,NR,-,-,-,MAPT,Parkinson's disease,Parkinson disease,-,GCST90308590,17:45987897
rs199453-T,1e-61,-,NR,-,-,-,NSF,Parkinson's disease,Parkinson disease,-,GCST90308590,17:46723580
rs61169879-T,2e-10,-,NR,-,-,-,BRIP1,Parkinson's disease,Parkinson disease,-,GCST90308590,17:61840005
rs8091977-T,4e-9,-,NR,-,-,-,"ASXL3,NOL4",Parkinson's disease,Parkinson disease,-,GCST90308590,18:33779450
rs55818311-T,1e-9,-,NR,-,-,-,SPPL2B,Parkinson's disease,Parkinson disease,-,GCST90308590,19:2341049
rs6060983-T,4e-9,-,NR,-,-,-,MYLK2,Parkinson's disease,Parkinson disease,-,GCST90308590,20:31833121
rs1736020-A,1e-9,-,NR,-,-,-,"CYCSP42,LINC02920",Parkinson's disease,Parkinson disease,-,GCST90308590,21:15440233
rs2248244-A,6e-10,-,NR,-,-,-,DYRK1A,Parkinson's disease,Parkinson disease,-,GCST90308590,21:37480059
rs36082764-?,6e-8,-,NR,-,0.62 unit decrease,[0.4-0.84],LINC00511,Parkinson disease axial motor severity,Parkinson disease,-,GCST90321084,17:72334038
rs4721411-?,2e-7,-,NR,-,0.53 unit increase,[0.33-0.73],MAD1L1,Parkinson disease axial motor severity,Parkinson disease,-,GCST90321084,7:2113436
rs10939702-?,8e-7,-,NR,-,0.57 unit increase,[0.33-0.81],WDR1,Parkinson disease axial motor severity,Parkinson disease,-,GCST90321084,4:10095068
rs76763715-?,2.9999999999999998e-90,-,NR,-,4.113 unit decrease,[3.71-4.51],GBA1,Parkinson disease,Parkinson disease,-,GCST90428733,1:155235843
rs114525519-?,9e-60,-,NR,-,2.563 unit decrease,[2.26-2.87],TRIM46,Parkinson disease,Parkinson disease,-,GCST90428733,1:155179361
rs116540837-?,2e-53,-,NR,-,2.383 unit decrease,[2.08-2.69],ASH1L,Parkinson disease,Parkinson disease,-,GCST90428733,1:155432750
rs116114495-?,2e-39,-,NR,-,2.134 unit decrease,[1.81-2.45],PBXIP1,Parkinson disease,Parkinson disease,-,GCST90428733,1:154951539
rs1630500-?,9.999999999999999e-38,-,NR,-,2.07 unit decrease,[1.75-2.39],"KCNN3,PMVK",Parkinson disease,Parkinson disease,-,GCST90428733,1:154882579
rs71628699-?,4e-36,-,NR,-,1.87 unit decrease,[1.58-2.16],ARHGEF2,Parkinson disease,Parkinson disease,-,GCST90428733,1:155974835
rs1749409-?,3e-34,-,NR,-,1.824 unit decrease,[1.53-2.12],RIT1,Parkinson disease,Parkinson disease,-,GCST90428733,1:155900625
rs41265017-?,9.999999999999999e-27,-,NR,-,1.657 unit decrease,[1.35-1.96],SEMA4A,Parkinson disease,Parkinson disease,-,GCST90428733,1:156176849
rs513043-?,2e-21,-,NR,-,1.416 unit decrease,[1.12-1.71],LMNA,Parkinson disease,Parkinson disease,-,GCST90428733,1:156129878
rs577492-?,3e-21,-,NR,-,1.413 unit decrease,[1.12-1.71],LMNA,Parkinson disease,Parkinson disease,-,GCST90428733,1:156130948
rs553016-?,4e-21,-,NR,-,1.407 unit decrease,[1.11-1.7],LMNA,Parkinson disease,Parkinson disease,-,GCST90428733,1:156137072
rs1800247-?,8e-10,-,NR,-,0.898 unit decrease,[0.61-1.18],PMF1-BGLAP,Parkinson disease,Parkinson disease,-,GCST90428733,1:156242034
rs2764407-?,4e-9,-,NR,-,0.861 unit decrease,[0.57-1.15],CCT3,Parkinson disease,Parkinson disease,-,GCST90428733,1:156364040
rs35902694-?,5e-8,-,NR,-,1.033 unit decrease,[0.66-1.4],EFNA4-EFNA3,Parkinson disease,Parkinson disease,-,GCST90428733,1:155070410
i709741-?,3e-7,-,NR,-,0.777 unit decrease,[0.48-1.07],-,Parkinson disease,Parkinson disease,-,GCST90428733,-
rs2049805-?,6e-7,-,NR,-,0.729 unit increase,[0.44-1.02],GBA1LP,Parkinson disease,Parkinson disease,-,GCST90428733,1:155225189
rs11264300-?,8e-7,-,NR,-,0.836 unit decrease,[0.5-1.17],"DCST1,DCST1-AS1",Parkinson disease,Parkinson disease,-,GCST90428733,1:155047234
rs7365544-?,9e-7,-,NR,-,0.719 unit increase,[0.43-1.01],"EFNA3,Y_RNA",Parkinson disease,Parkinson disease,-,GCST90428733,1:155096272
rs28445596-?,1e-6,-,NR,-,0.711 unit increase,[0.42-1],GBA1LP,Parkinson disease,Parkinson disease,-,GCST90428733,1:155216938
rs1218566-?,1e-6,-,NR,-,0.809 unit decrease,[0.48-1.14],KCNN3,Parkinson disease,Parkinson disease,-,GCST90428733,1:154845097
rs670523-?,1e-6,-,NR,-,0.794 unit decrease,[0.47-1.12],RIT1,Parkinson disease,Parkinson disease,-,GCST90428733,1:155908941
rs4072037-?,1e-6,-,NR,-,1.065 unit decrease,[0.63-1.5],MUC1,Parkinson disease,Parkinson disease,-,GCST90428733,1:155192276
rs7367207-?,1e-6,-,NR,-,0.696 unit increase,[0.41-0.98],"Y_RNA,EFNA3",Parkinson disease,Parkinson disease,-,GCST90428733,1:155107001
rs11264275-?,2e-6,-,NR,-,1.086 unit decrease,[0.64-1.53],KCNN3,Parkinson disease,Parkinson disease,-,GCST90428733,1:154852794
rs4845404-?,2e-6,-,NR,-,0.808 unit decrease,[0.48-1.14],DCST1,Parkinson disease,Parkinson disease,-,GCST90428733,1:155034817
rs75337321-?,2e-6,-,NR,-,0.83 unit decrease,[0.49-1.17],CACNA2D3,Parkinson disease,Parkinson disease,-,GCST90428733,3:54550560
rs17377936-?,2e-6,-,NR,-,0.682 unit increase,[0.4-0.97],"MTND1P22,GUCY1A1",Parkinson disease,Parkinson disease,-,GCST90428733,4:155466679
rs58519469-?,3e-6,-,NR,-,0.896 unit decrease,[0.52-1.27],NTRK1,Parkinson disease,Parkinson disease,-,GCST90428733,1:156878696
rs10908458-?,3e-6,-,NR,-,0.675 unit increase,[0.39-0.96],"HMGN2P18,KRTCAP2",Parkinson disease,Parkinson disease,-,GCST90428733,1:155154472
rs2798604-?,3e-6,-,NR,-,0.749 unit decrease,[0.43-1.06],KCNN3,Parkinson disease,Parkinson disease,-,GCST90428733,1:154825677
rs111408331-?,3e-6,-,NR,-,0.944 unit decrease,[0.55-1.34],"SSBP4,LRRC25",Parkinson disease,Parkinson disease,-,GCST90428733,19:18403904
rs79372348-?,4e-6,-,NR,-,1.007 unit decrease,[0.58-1.44],"LRRC30,PTPRM",Parkinson disease,Parkinson disease,-,GCST90428733,18:7234107
rs186852039-?,4e-6,-,NR,-,0.921 unit decrease,[0.53-1.31],GBA2,Parkinson disease,Parkinson disease,-,GCST90428733,9:35742005
rs11772125-?,4e-6,-,NR,-,0.799 unit decrease,[0.46-1.14],"AMZ1,GNA12",Parkinson disease,Parkinson disease,-,GCST90428733,7:2757620
rs11584630-?,5e-6,-,NR,-,0.747 unit decrease,[0.43-1.07],KCNN3,Parkinson disease,Parkinson disease,-,GCST90428733,1:154835459
rs12028043-?,7e-6,-,NR,-,0.649 unit increase,[0.37-0.93],"KRTCAP2,HMGN2P18",Parkinson disease,Parkinson disease,-,GCST90428733,1:155160360
rs72792300-?,7e-6,-,NR,-,1.178 unit decrease,[0.66-1.69],ALK,Parkinson disease,Parkinson disease,-,GCST90428733,2:29865460
rs199351-A,4.0000000000000003e-28,-,NR,-,-,-,GPNMB,Parkinson's disease,Parkinson disease,-,GCST90308590,7:23260430
rs114138760-C,3e-9,(random effect),NR,-,-,-,PMVK,Parkinson's disease,Parkinson disease,-,GCST90308590,1:154925709
rs6469271-T,2e-7,-,NR,-,-,-,SYBU,Parkinson's disease,Parkinson disease,-,GCST90308590,8:109632545
rs10756905-T,2e-20,-,NR,-,-,-,SH3GL2,Parkinson's disease,Parkinson disease,-,GCST90308590,9:17726890
rs6476434-T,1e-9,-,NR,-,-,-,UBAP2,Parkinson's disease,Parkinson disease,-,GCST90308590,9:34046393
rs118117788-T,4.0000000000000004e-23,(random effect),NR,-,-,-,"SEC23IP,MIR4682",Parkinson's disease,Parkinson disease,-,GCST90308590,10:119950976
rs148163066-A,7e-11,(random effect),NR,-,-,-,PKP2,Parkinson's disease,Parkinson disease,-,GCST90308590,12:32826971
rs4421827-A,2e-14,(random effect),NR,-,-,-,"Y_RNA,RNU6-472P",Parkinson's disease,Parkinson disease,-,GCST90308590,12:33974571
rs28370650-A,2.9999999999999998e-33,-,NR,-,-,-,SLC2A13,Parkinson's disease,Parkinson disease,-,GCST90308590,12:40006146
rs17442721-C,9e-27,(random effect),NR,-,-,-,LINC02555,Parkinson's disease,Parkinson disease,-,GCST90308590,12:40141971
rs17443414-A,3e-10,-,NR,-,-,-,LRRK2,Parkinson's disease,Parkinson disease,-,GCST90308590,12:40250950
rs190807041-G,1e-13,(random effect),NR,-,-,-,"LRRK2,MUC19",Parkinson's disease,Parkinson disease,-,GCST90308590,12:40379882
rs4698412-A,5.9999999999999997e-33,-,NR,-,-,-,BST1,Parkinson's disease,Parkinson disease,-,GCST90308590,4:15735725
rs1550556-T,1e-8,-,NR,-,-,-,SCARB2,Parkinson's disease,Parkinson disease,-,GCST90308590,4:76173388
rs4859676-A,8e-8,-,NR,-,-,-,SHROOM3,Parkinson's disease,Parkinson disease,-,GCST90308590,4:76457698
rs6582586-A,6e-8,-,NR,-,-,-,"SLC38A1,RPL13AP21",Parkinson's disease,Parkinson disease,-,GCST90308590,12:46022959
rs78299420-T,3e-9,(random effect),NR,-,-,-,PITPNM2,Parkinson's disease,Parkinson disease,-,GCST90308590,12:123086549
rs145138919-T,5e-9,(random effect),NR,-,-,-,CCSER1,Parkinson's disease,Parkinson disease,-,GCST90308590,4:90531895
rs11610045-A,5e-11,-,NR,-,-,-,"FBRSL1,GALNT9",Parkinson's disease,Parkinson disease,-,GCST90308590,12:132487182
rs7434295-T,2e-11,-,NR,-,-,-,CLCN3,Parkinson's disease,Parkinson disease,-,GCST90308590,4:169642795
rs11956597-A,8e-8,-,NR,-,-,-,DDX46,Parkinson's disease,Parkinson disease,-,GCST90308590,5:134763068
rs8018800-A,4e-16,-,NR,-,-,-,WDHD1,Parkinson's disease,Parkinson disease,-,GCST90308590,14:54986588
rs8012377-T,2e-10,(random effect),NR,-,-,-,"RPL13AP3,KTN1",Parkinson's disease,Parkinson disease,-,GCST90308590,14:55724695
rs112288215-T,3e-7,-,NR,-,-,-,AREL1,Parkinson's disease,Parkinson disease,-,GCST90308590,14:74688182
rs28648524-A,3e-8,-,NR,-,-,-,"USP50,USP8",Parkinson's disease,Parkinson disease,-,GCST90308590,15:50495212
rs2251086-T,5e-22,-,NR,-,-,-,"RORA,LINC02349",Parkinson's disease,Parkinson disease,-,GCST90308590,15:61705186
rs34133110-T,1e-9,-,NR,-,-,-,NOD2,Parkinson's disease,Parkinson disease,-,GCST90308590,16:50710008
rs11164870-C,3e-9,-,NR,-,-,-,MTF2,Parkinson's disease,Parkinson disease,-,GCST90308590,1:93086630
rs1293298-A,2e-14,-,NR,-,-,-,CTSB,Parkinson's disease,Parkinson disease,-,GCST90308590,8:11854934
rs146143531-T,2e-10,(random effect),NR,-,-,-,DCST1,Parkinson's disease,Parkinson disease,-,GCST90308590,1:155042492
rs35682329-A,1.0000000000000001e-75,(random effect),NR,-,-,-,HMGN2P18,Parkinson's disease,Parkinson disease,-,GCST90308590,1:155148667
rs10737170-A,3e-10,-,NR,-,-,-,LMNA,Parkinson's disease,Parkinson disease,-,GCST90308590,1:156094089
rs35161831-T,1e-15,(random effect),NR,-,-,-,CCT3,Parkinson's disease,Parkinson disease,-,GCST90308590,1:156330940
rs6658353-C,2e-11,-,NR,-,-,-,"FCGR2A,RNU6-481P",Parkinson's disease,Parkinson disease,-,GCST90308590,1:161499264
rs17411858-A,5e-9,(random effect),NR,-,-,-,"FCGR3B,FCGR2B",Parkinson's disease,Parkinson disease,-,GCST90308590,1:161647726
rs1108439-A,2e-8,-,NR,-,-,-,TBC1D5,Parkinson's disease,Parkinson disease,-,GCST90308590,3:18159827
rs16833168-T,3e-12,(random effect),NR,-,-,-,PARP9,Parkinson's disease,Parkinson disease,-,GCST90308590,3:122535800
rs6806917-T,3e-9,-,NR,-,-,-,PIK3CA-DT,Parkinson's disease,Parkinson disease,-,GCST90308590,3:179143629
rs10513789-T,6e-50,-,NR,-,-,-,MCCC1,Parkinson's disease,Parkinson disease,-,GCST90308590,3:183042285
rs71314284-T,1e-8,-,NR,-,-,-,LAMP3,Parkinson's disease,Parkinson disease,-,GCST90308590,3:183160467
rs16843452-T,3e-7,-,NR,-,-,-,ADD1,Parkinson's disease,Parkinson disease,-,GCST90308590,4:2847441
rs11177328-A,3e-11,(random effect),NR,-,-,-,"CNTN1,MUC19",Parkinson's disease,Parkinson disease,-,GCST90308590,12:40583994
rs1442190-A,2e-15,-,NR,-,-,-,CNTN1,Parkinson's disease,Parkinson disease,-,GCST90308590,12:40971838
rs114762839-A,1e-10,(random effect),NR,-,-,-,"GPRIN3,SNCA",Parkinson's disease,Parkinson disease,-,GCST90308590,4:89447394
rs79483792-T,3e-17,-,NR,-,-,-,"SNCA,GPRIN3",Parkinson's disease,Parkinson disease,-,GCST90308590,4:89582510
rs78327649-C,2e-12,(random effect),NR,-,-,-,"CCSER1,MMRN1",Parkinson's disease,Parkinson disease,-,GCST90308590,4:90059181
rs28659953-T,3e-8,-,NR,-,-,-,RILPL2,Parkinson's disease,Parkinson disease,-,GCST90308590,12:123427666
rs13117519-T,3e-11,-,NR,-,-,-,CAMK2D,Parkinson's disease,Parkinson disease,-,GCST90308590,4:113447909
rs1127021-T,2e-8,-,NR,-,-,-,KPNA3,Parkinson's disease,Parkinson disease,-,GCST90308590,13:49721979
rs9393826-A,1e-8,-,NR,-,-,-,"CD83P1,RNU6-471P",Parkinson's disease,Parkinson disease,-,GCST90308590,6:27584991
rs3796661-C,4e-13,-,NR,0.69,-,[0.62-0.76],SNCA,Parkinson's disease,Parkinson disease,-,GCST90278092,4:89766356
rs34778348-A,5e-13,-,NR,2.56,-,[1.99-3.31],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90278092,12:40363526
rs708726-T,2e-8,-,NR,0.75,-,[0.68-0.83],SLC41A1,Parkinson's disease,Parkinson disease,-,GCST90278092,1:205793011
rs2451713-C,5e-8,-,NR,1.88,-,[1.5-2.36],"GUSBP2,ZNF322",Parkinson's disease,Parkinson disease,-,GCST90278092,6:26660427
rs708723-C,7e-8,-,NR,0.76,-,[0.69-0.84],RAB29,Parkinson's disease,Parkinson disease,-,GCST90278092,1:205770138
rs34778348-A,2e-9,-,NR,3.53,-,[2.35-5.29],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90296432,12:40363526
rs3796661-C,5e-9,-,NR,0.63,-,[0.54-0.74],SNCA,Parkinson's disease,Parkinson disease,-,GCST90296432,4:89766356
rs708726-T,8e-6,-,NR,0.67,-,[0.57-0.79],SLC41A1,Parkinson's disease,Parkinson disease,-,GCST90296433,1:205793011
rs139422381-A,2e-6,-,NR,4.02,-,[2.25-7.16],ROPN1L,Parkinson's disease,Parkinson disease,-,GCST90296433,5:10558686
rs947211-A,3e-6,-,NR,0.69,-,[0.59-0.8],"SLC41A1,RAB29",Parkinson's disease,Parkinson disease,-,GCST90296433,1:205783537
rs10746109-A,4e-6,-,NR,1.46,-,[1.24-1.71],"WSCD2,ASCL4",Parkinson's disease,Parkinson disease,-,GCST90296433,12:108067384
rs12748961-T,5e-6,-,NR,0.69,-,[0.59-0.81],"Metazoa_SRP,NUCKS1",Parkinson's disease,Parkinson disease,-,GCST90296433,1:205707135
rs1949132-C,7e-6,-,NR,1.78,-,[1.39-2.29],"RN7SL869P,RN7SL35P",Parkinson's disease,Parkinson disease,-,GCST90296433,7:80250162
rs111841435-C,4e-6,-,0.144,1.1,-,[1.06-1.15],PTCHD1-AS,Parkinson's disease,Parkinson disease,-,GCST90104086,X:23324255
rs28602900-A,4e-7,-,0.115,1.11,-,[1.07-1.15],"DNASE1L1,RPL10",Parkinson's disease,Parkinson disease,-,GCST90104086,X:154405192
rs7066890-T,1e-8,-,0.155,1.1,-,[1.06-1.13],GPM6B,Parkinson's disease,Parkinson disease,-,GCST90104087,X:13874463
rs11796528-A,1e-6,-,0.169,1.08,-,[1.05-1.11],"PJA1,EFNB1",Parkinson's disease,Parkinson disease,-,GCST90104087,X:69159006
rs41306249-T,1e-7,-,0.047,1.15,-,[1.09-1.22],RTL9,Parkinson's disease,Parkinson disease,-,GCST90104087,X:110454215
rs28602900-A,1e-9,-,0.115,1.1,-,[1.07-1.14],"DNASE1L1,RPL10",Parkinson's disease,Parkinson disease,-,GCST90104087,X:154405192
rs421016-G,1e-14,-,NR,-,1.979 unit increase,[1.48-2.48],GBA1,Parkinson's disease,Parkinson disease,-,GCST90270939,1:155235252
rs823118-C,1.0000000000000001e-23,-,NR,-,0.208 unit decrease,[0.17-0.25],"NUCKS1,RAB29",Parkinson's disease,Parkinson disease,-,GCST90270939,1:205754444
rs11557080-G,1.0000000000000001e-24,-,NR,-,0.215 unit decrease,[0.17-0.26],RAB29,Parkinson's disease,Parkinson disease,-,GCST90270939,1:205768611
rs10748818-G,3e-6,-,NR,-,0.098 unit increase,[0.057-0.139],GBF1,Parkinson's disease,Parkinson disease,-,GCST90270939,10:102255522
rs7938782-G,1e-5,-,NR,-,0.123 unit decrease,[0.068-0.178],RNF141,Parkinson's disease,Parkinson disease,-,GCST90270939,11:10537230
rs10847864-G,4e-7,-,NR,-,0.102 unit decrease,[0.063-0.141],HIP1R,Parkinson's disease,Parkinson disease,-,GCST90270939,12:122842051
rs34594498-T,4e-20,-,NR,-,0.883 unit increase,[0.69-1.07],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90270939,12:40252984
rs34778348-C,3e-30,-,NR,-,0.608 unit increase,[0.5-0.71],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90270939,12:40363526
rs11158026-C,2e-9,-,NR,-,0.12 unit increase,[0.081-0.159],GCH1,Parkinson's disease,Parkinson disease,-,GCST90270939,14:54882151
rs2251086-T,1e-9,-,NR,-,0.164 unit decrease,[0.11-0.22],"RORA,LINC02349",Parkinson's disease,Parkinson disease,-,GCST90270939,15:61705186
rs61204179-T,1e-9,-,NR,-,0.291 unit increase,[0.2-0.39],HEATR6,Parkinson's disease,Parkinson disease,-,GCST90270939,17:60061921
rs12456492-G,2e-7,-,NR,-,0.106 unit increase,[0.067-0.145],RIT2,Parkinson's disease,Parkinson disease,-,GCST90270939,18:43093415
rs2248244-A,4e-7,-,NR,-,0.105 unit increase,[0.064-0.146],DYRK1A,Parkinson's disease,Parkinson disease,-,GCST90270939,21:37480059
rs10513789-T,4e-17,-,NR,-,0.173 unit increase,[0.13-0.21],MCCC1,Parkinson's disease,Parkinson disease,-,GCST90270939,3:183042285
rs4698412-A,1e-13,-,NR,-,0.15 unit increase,[0.11-0.19],BST1,Parkinson's disease,Parkinson disease,-,GCST90270939,4:15735725
rs6825004-G,3e-6,-,NR,-,0.097 unit decrease,[0.056-0.138],SCARB2,Parkinson's disease,Parkinson disease,-,GCST90270939,4:76189212
rs356182-A,3e-53,-,NR,-,0.343 unit decrease,[0.3-0.39],SNCA,Parkinson's disease,Parkinson disease,-,GCST90270939,4:89704960
rs34311866-C,3e-6,-,NR,-,0.134 unit increase,[0.077-0.191],TMEM175,Parkinson's disease,Parkinson disease,-,GCST90270939,4:958159
rs997368-G,1e-8,-,NR,-,0.119 unit decrease,[0.078-0.16],"LINC02527,CCN6",Parkinson's disease,Parkinson disease,-,GCST90270939,6:111922088
rs2230288-T,1e-18,-,NR,-,0.4 unit increase,-,GBA1,Parkinson's disease,Parkinson disease,-,GCST90455618,1:155236376
rs9917256-A,8e-11,-,NR,-,0.15 unit increase,-,"RN7SL813P,STK39",Parkinson's disease,Parkinson disease,-,GCST90455618,2:168286525
rs34311866-C,1e-12,-,NR,-,0.17 unit increase,-,TMEM175,Parkinson's disease,Parkinson disease,-,GCST90455618,4:958159
rs1372519-G,3e-12,-,NR,-,0.18 unit increase,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST90455618,4:89836158
rs2760980-A,3e-9,-,NR,-,0.15 unit decrease,-,"HLA-DQA1,HLA-DRB1",Parkinson's disease,Parkinson disease,-,GCST90455618,6:32597424
rs34637584-A,7e-12,-,NR,-,2.27 unit increase,-,LRRK2,Parkinson's disease,Parkinson disease,-,GCST90455618,12:40340400
rs10847839-C,5e-8,-,NR,-,0.14 unit decrease,-,HIP1R,Parkinson's disease,Parkinson disease,-,GCST90455618,12:122838013
rs11158026-T,3e-8,-,NR,-,0.1 unit decrease,-,GCH1,Parkinson's disease,Parkinson disease,-,GCST90455618,14:54882151
rs4630591-T,1e-18,-,NR,-,0.25 unit decrease,-,KANSL1,Parkinson's disease,Parkinson disease,-,GCST90455618,17:46115202
rs6857-T,2e-9,-,NR,-,0.13 unit increase,-,"NECTIN2,LNCOB1",Parkinson's disease,Parkinson disease,-,GCST90455618,19:44888997
rs145330152-C,1e-9,-,0.01357,2.22123,-,[1.71904-2.87012},ASH1L,Parkinson's disease,Parkinson disease,-,GCST012431,1:155401328
rs187989831-C,8e-10,-,0.005,3.59353E-4,-,[0.0000287389-0.00449338},"TEKT4,MTCO1P48",Parkinson's disease,Parkinson disease,-,GCST012431,2:94894760
rs34311866-C,6e-11,-,0.31849,1.25164,-,[1.17023-1.33871},TMEM175,Parkinson's disease,Parkinson disease,-,GCST012431,4:958159
rs983361-T,6e-9,-,0.217,0.819506,-,[0.766273-0.876438},SNCA-AS1,Parkinson's disease,Parkinson disease,-,GCST012431,4:89840793
rs137887044-C,2e-8,-,0.972,1.8504,-,[1.4908-2.27},WDR41,Parkinson's disease,Parkinson disease,-,GCST012431,5:77616673
rs78837976-C,3e-18,-,0.989,16.6736,-,[9.0911-33.3347},MUC12,Parkinson's disease,Parkinson disease,-,GCST012431,7:101004230
rs74125032-T,2e-10,-,0.002,4.49847E-10,-,[0.000000000000577807-0.000000350225},CARS2,Parkinson's disease,Parkinson disease,-,GCST012431,13:110677242
rs117672332-T,2e-15,-,0.989,7.6928,-,[4.7648-12.5073},"ITGAE,P2RX5",Parkinson's disease,Parkinson disease,-,GCST012431,17:3702823
rs7221167-C,3e-8,-,0.396,0.847932,-,[0.799836-0.898921},MAPT-AS1,Parkinson's disease,Parkinson disease,-,GCST012431,17:45855941
rs199501-A,8e-12,-,0.22413,0.794626,-,[0.743956-0.848747},WNT3,Parkinson's disease,Parkinson disease,-,GCST012431,17:46785247
rs35749011-A,5e-11,-,0.0153,2.24146,-,[1.76182-2.85169},"KRTCAP2,HMGN2P18",Parkinson's disease,Parkinson disease,-,GCST012431,1:155162560
rs3806789-C,9e-10,(conditioned on rs356182),0.4951,0.8265,-,NR,SNCA-AS1,Parkinson's disease,Parkinson disease,-,GCST012431,4:89838405
rs74125084-T,1e-7,-,0.0058,1.058E-4,-,NR,ING1,Parkinson's disease,Parkinson disease,-,GCST012431,13:110720333
rs11653889-A,1e-14,-,0.0072,0.0499,-,NR,"HASPIN,ITGAE",Parkinson's disease,Parkinson disease,-,GCST012431,17:3724162
rs356182-?,5e-8,-,NR,-,0.234 unit increase,[0.15-0.32],SNCA,Parkinson's disease,Parkinson disease,-,GCST90026456,4:89704960
rs116504637-T,1e-6,-,0.74,-,0.35 unit increase,[0.21-0.49],CYP4Z1,Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,1:47092261
rs11949046-T,2e-6,-,0.89,-,0.54 unit increase,[0.32-0.76],"RNU6-164P,GABRG2",Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,5:162251793
rs78926797-A,2e-6,-,0.6,-,0.3 unit decrease,[0.18-0.42],TMC5,Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,16:19491341
rs6932127-T,3e-6,-,0.89,-,0.46 unit decrease,[0.26-0.66],"NKAIN2,RNF217-AS1",Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,6:124786353
rs55971529-A,4e-6,-,0.97,-,1.08 unit decrease,[0.63-1.53],"LINC01495,FANCF",Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,11:22561522
rs988295487-C,5e-6,-,0.96,-,0.84 unit decrease,[0.49-1.19],"TPI1P1,RNU6-161P",Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,1:76725240
rs13330839-A,7e-6,-,0.87,-,0.47 unit decrease,[0.27-0.67],MPHOSPH6-DT,Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty),Parkinson disease,-,GCST90000014,16:82246021
rs302714-A,4e-6,-,NR,-,0.0698 unit increase,[0.04-0.1],"RERE-AS1,RERE",Parkinson's disease,Parkinson disease,-,GCST010991,1:8426071
rs28624974-T,8e-12,-,NR,-,0.1016 unit increase,[0.072-0.131],KLHL7,Parkinson's disease,Parkinson disease,-,GCST010991,7:23149317
rs1293298-A,6e-11,-,NR,-,0.1103 unit increase,[0.077-0.143],CTSB,Parkinson's disease,Parkinson disease,-,GCST010991,8:11854934
rs11203810-T,2e-8,-,NR,-,0.0895 unit decrease,[0.058-0.121],"MSR1,RN7SL474P",Parkinson's disease,Parkinson disease,-,GCST010991,8:16854852
rs4921739-T,6e-6,-,NR,-,0.0813 unit decrease,[0.046-0.117],ZDHHC2,Parkinson's disease,Parkinson disease,-,GCST010991,8:17172148
rs13294100-T,3e-10,-,NR,-,0.0942 unit decrease,[0.065-0.124],SH3GL2,Parkinson's disease,Parkinson disease,-,GCST010991,9:17579692
rs2278973-T,3e-7,-,NR,-,0.1373 unit increase,[0.085-0.19],CACNA1B,Parkinson's disease,Parkinson disease,-,GCST010991,9:138121810
rs10906923-A,3e-7,-,NR,-,0.0768 unit increase,[0.047-0.106],ITGA8,Parkinson's disease,Parkinson disease,-,GCST010991,10:15527599
rs144814361-T,2e-12,-,NR,-,0.468 unit increase,[0.34-0.6],BAG3,Parkinson's disease,Parkinson disease,-,GCST010991,10:119651405
rs3793947-A,5e-7,-,NR,-,0.0715 unit decrease,[0.044-0.099],DLG2,Parkinson's disease,Parkinson disease,-,GCST010991,11:83833429
rs3802920-T,7e-9,-,NR,-,0.1012 unit increase,[0.067-0.135],IGSF9B,Parkinson's disease,Parkinson disease,-,GCST010991,11:133917106
rs4653767-T,6e-8,-,NR,-,0.0846 unit increase,[0.054-0.115],ITPKB,Parkinson's disease,Parkinson disease,-,GCST010991,1:226728377
rs144029582-A,4e-7,-,NR,-,0.3265 unit increase,[0.2-0.45],"MTND1P24,LINC02400",Parkinson's disease,Parkinson disease,-,GCST010991,12:41754811
rs11060112-A,2e-10,-,NR,-,0.1102 unit increase,[0.076-0.144],CCDC62,Parkinson's disease,Parkinson disease,-,GCST010991,12:122807956
rs11158026-T,1e-10,-,NR,-,0.0993 unit decrease,[0.069-0.129],GCH1,Parkinson's disease,Parkinson disease,-,GCST010991,14:54882151
rs8005172-T,6e-10,-,NR,-,0.086 unit increase,[0.059-0.113],GPR65,Parkinson's disease,Parkinson disease,-,GCST010991,14:88006268
rs12467316-A,5e-7,-,NR,-,0.0753 unit increase,[0.046-0.105],LINC01127,Parkinson's disease,Parkinson disease,-,GCST010991,2:101988187
rs6430538-T,1e-13,-,NR,-,0.1094 unit decrease,[0.081-0.138],CCNT2-AS1,Parkinson's disease,Parkinson disease,-,GCST010991,2:134782397
rs148534175-T,1e-8,-,NR,-,0.1113 unit increase,[0.073-0.149],"MED13,Y_RNA",Parkinson's disease,Parkinson disease,-,GCST010991,17:62120839
rs12456492-A,2e-9,-,NR,-,0.0892 unit decrease,[0.06-0.118],RIT2,Parkinson's disease,Parkinson disease,-,GCST010991,18:43093415
rs113732002-A,3e-7,-,NR,-,0.1272 unit decrease,[0.079-0.176],NGEF,Parkinson's disease,Parkinson disease,-,GCST010991,2:232982170
rs13078687-A,9e-9,-,NR,-,0.1206 unit increase,[0.079-0.162],TBC1D5,Parkinson's disease,Parkinson disease,-,GCST010991,3:18181950
rs55740225-T,3e-7,-,NR,-,0.0946 unit decrease,[0.058-0.131],PARP9,Parkinson's disease,Parkinson disease,-,GCST010991,3:122549781
rs181870458-A,2e-7,-,NR,-,0.4355 unit increase,[0.27-0.6],"LARP7P4,RNA5SP144",Parkinson's disease,Parkinson disease,-,GCST010991,3:145333493
rs2276765-A,2e-7,-,NR,-,0.0761 unit increase,[0.047-0.105],MED12L,Parkinson's disease,Parkinson disease,-,GCST010991,3:151413434
rs1450522-A,6e-8,-,NR,-,0.0797 unit decrease,[0.051-0.109],SPTSSB,Parkinson's disease,Parkinson disease,-,GCST010991,3:161359842
rs140278703-T,2e-11,-,NR,-,0.1671 unit decrease,[0.12-0.22],MCCC1,Parkinson's disease,Parkinson disease,-,GCST010991,3:183034255
rs34884217-A,1e-11,-,NR,-,0.1915 unit increase,[0.14-0.25],TMEM175,Parkinson's disease,Parkinson disease,-,GCST010991,4:950422
rs12651314-T,2e-11,-,NR,-,0.1179 unit decrease,[0.083-0.152],BST1,Parkinson's disease,Parkinson disease,-,GCST010991,4:15751947
rs12643261-T,4e-11,-,NR,-,0.1585 unit decrease,[0.11-0.21],"FAM47E,FAM47E-STBD1",Parkinson's disease,Parkinson disease,-,GCST010991,4:76255695
rs10516839-T,4e-17,-,NR,-,0.1382 unit decrease,[0.11-0.17],"GPRIN3,SNCA",Parkinson's disease,Parkinson disease,-,GCST010991,4:89587189
rs13107325-T,7e-8,-,NR,-,0.1495 unit decrease,[0.095-0.204],SLC39A8,Parkinson's disease,Parkinson disease,-,GCST010991,4:102267552
rs17483653-A,5e-7,-,NR,-,0.1043 unit increase,[0.064-0.145],CAMK2D,Parkinson's disease,Parkinson disease,-,GCST010991,4:113422713
rs1867598-A,7e-10,-,NR,-,0.1444 unit decrease,[0.099-0.19],ELOVL7,Parkinson's disease,Parkinson disease,-,GCST010991,5:60842132
rs6875262-T,3e-9,-,NR,-,0.1639 unit increase,[0.11-0.22],"LINC02240,ZNF608",Parkinson's disease,Parkinson disease,-,GCST010991,5:124774580
rs2647062-A,6e-12,-,NR,-,0.143 unit increase,[0.1-0.18],"HLA-DQA1,HLA-DRB1",Parkinson's disease,Parkinson disease,-,GCST010991,6:32602640
rs943437-A,2e-7,-,NR,-,0.1105 unit increase,[0.069-0.152],"CCN6,LINC02527",Parkinson's disease,Parkinson disease,-,GCST010991,6:111921050
rs34372695-T,4e-12,-,NR,-,0.3189 unit increase,[0.23-0.41],"RAB25,LAMTOR2",Parkinson's disease,Parkinson disease,-,GCST010991,1:156060246
rs4915466-T,1e-6,-,NR,-,0.0706 unit increase,[0.042-0.099],MROH3P,Parkinson's disease,Parkinson disease,-,GCST010991,1:200936379
rs3805-T,4e-11,-,NR,-,0.132 unit decrease,[0.093-0.171],NUCKS1,Parkinson's disease,Parkinson disease,-,GCST010991,1:205714227
rs77669894-A,4e-8,-,NR,-,0.3283 unit increase,[0.21-0.45],BICD1-AS1,Parkinson's disease,Parkinson disease,-,GCST010991,12:32089513
rs138895122-T,6e-12,-,NR,-,0.6116 unit increase,[0.44-0.79],"SYT10,ASS1P14",Parkinson's disease,Parkinson disease,-,GCST010991,12:33075690
rs28370664-A,7e-26,-,NR,-,0.4475 unit increase,[0.36-0.53],SLC2A13,Parkinson's disease,Parkinson disease,-,GCST010991,12:40019503
rs10797576-T,2e-7,-,NR,-,0.1045 unit increase,[0.065-0.144],SIPA1L2,Parkinson's disease,Parkinson disease,-,GCST010991,1:232528865
rs3889108-T,7e-9,-,NR,-,0.1322 unit decrease,[0.088-0.177],"LINC02349,RORA",Parkinson's disease,Parkinson disease,-,GCST010991,15:61712597
rs1027647-A,2e-6,-,NR,-,0.0698 unit increase,[0.041-0.099],"TPM1,LACTB",Parkinson's disease,Parkinson disease,-,GCST010991,15:63082626
rs140820592-T,1e-8,-,NR,-,0.0859 unit decrease,[0.056-0.115],STX1B,Parkinson's disease,Parkinson disease,-,GCST010991,16:31010559
rs113564729-A,2e-11,-,NR,-,0.0994 unit increase,[0.07-0.129],KANSL1,Parkinson's disease,Parkinson disease,-,GCST010991,17:46101729
rs4667572-A,4e-13,-,NR,-,0.1377 unit increase,[0.1-0.17],"RN7SL813P,STK39",Parkinson's disease,Parkinson disease,-,GCST010991,2:168299490
rs8087969-T,5e-6,-,NR,-,0.0645 unit decrease,[0.037-0.092],"SMAD4,SRSF10P1",Parkinson's disease,Parkinson disease,-,GCST010991,18:51157219
rs6060983-T,6e-7,-,NR,-,0.0767 unit increase,[0.047-0.107],MYLK2,Parkinson's disease,Parkinson disease,-,GCST010991,20:31833121
rs11701722-T,5e-8,-,NR,-,0.083 unit decrease,[0.053-0.113],DYRK1A,Parkinson's disease,Parkinson disease,-,GCST010991,21:37398228
rs56379273-A,9e-8,-,NR,-,0.3655 unit increase,[0.23-0.5],TRPM2,Parkinson's disease,Parkinson disease,-,GCST010991,21:44406603
rs2979160-A,3e-6,-,NR,-,-,-,LINC02950,Parkinson's disease,Parkinson disease,-,GCST010991,8:8450156
rs9468195-A,2e-9,-,NR,-,-,-,LINC01012,Parkinson's disease,Parkinson disease,-,GCST010991,6:27708530
rs3773384-C,4e-6,-,0.58,2.3255813,-,[1.28-12.5],"CHL1-AS1,CHL1",Parkinsonism in frontotemporal lobe dementia,Parkinson disease,frontotemporal dementia,GCST006153,3:374758
rs34656641-C,8e-6,-,0.08,3.26,-,[2.75-3.77],SP1,Parkinsonism in frontotemporal lobe dementia,Parkinson disease,frontotemporal dementia,GCST006153,12:53403452
rs17833740-T,9e-6,-,0.29,2.17,-,[1.84-2.50],LINC01500,Parkinsonism in frontotemporal lobe dementia,Parkinson disease,frontotemporal dementia,GCST006153,14:59154251
rs356219-?,2e-11,-,NR,1.29,-,[1.198-1.391],SNCA,Parkinson's disease in GBA mutation carriers,Parkinson disease,GBA carrier status,GCST009373,4:89716450
rs1293298-?,6e-6,-,NR,1.22,-,[1.12-1.32],CTSB,Parkinson's disease in GBA mutation carriers,Parkinson disease,GBA carrier status,GCST009373,8:11854934
rs356182-G,2e-9,-,0.34261,-,0.223036 unit increase,[0.15-0.3],SNCA,Parkinson's disease,Parkinson disease,-,GCST009512,4:89704960
rs190807041-G,7e-11,-,0.01044,-,2.03403 unit increase,[1.42-2.65],"LRRK2,MUC19",Parkinson's disease,Parkinson disease,-,GCST009512,12:40379882
rs113434679-A,9e-13,-,0.22119,-,0.311323 unit decrease,[0.23-0.4],KANSL1,Parkinson's disease,Parkinson disease,-,GCST009512,17:46049399
rs9275152-C,2e-8,-,0.08263,-,0.376551 unit decrease,[0.25-0.51],"HLA-DQB1,MTCO3P1",Parkinson's disease,Parkinson disease,-,GCST009512,6:32684419
rs62053943-T,8e-9,-,0.17489,-,0.2957 unit decrease,[0.2-0.4],LINC02210-CRHR1,Parkinson's disease,Parkinson disease,-,GCST009512,17:45666837
rs34311866-C,3e-7,-,0.16547,-,0.2425 unit increase,[0.15-0.34],TMEM175,Parkinson's disease,Parkinson disease,-,GCST009512,4:958159
rs11150601-G,6e-6,-,0.32723,-,0.1669 unit decrease,[0.095-0.239],SETD1A,Parkinson's disease,Parkinson disease,-,GCST009512,16:30966478
rs114138760-C,4e-9,-,0.0112,-,0.2812 unit increase,[0.19-0.37],PMVK,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:154925709
rs35749011-A,2e-70,-,0.0169,-,0.6068 unit increase,[0.54-0.67],"KRTCAP2,HMGN2P18",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:155162560
rs76763715-T,2e-22,-,0.9953,-,0.7467 unit decrease,[0.6-0.9],GBA1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:155235843
rs6658353-C,6e-12,-,0.5011,-,0.065 unit increase,[0.047-0.083],"FCGR2A,RNU6-481P",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:161499264
rs11578699-T,4e-9,-,0.1949,-,0.0704 unit decrease,[0.047-0.094],"METTL13,VAMP4",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:171750629
rs823118-T,1.0000000000000001e-29,-,0.566,-,0.1066 unit increase,[0.088-0.125],"NUCKS1,RAB29",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:205754444
rs11557080-A,3e-22,-,0.1389,-,0.1315 unit increase,[0.11-0.16],RAB29,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:205768611
rs4653767-T,1e-15,-,0.7196,-,0.0833 unit increase,[0.063-0.104],ITPKB,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:226728377
rs13117519-T,1e-12,-,0.1744,-,0.0875 unit increase,[0.063-0.112],CAMK2D,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:113447909
rs2042477-A,1e-8,-,0.2422,-,0.0657 unit decrease,[0.043-0.088],KCNIP3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:95335195
rs11683001-A,8e-13,-,0.337,-,0.0705 unit increase,[0.051-0.09],MAP4K4,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:101780501
rs1867598-A,3e-23,-,0.9019,-,0.1554 unit decrease,[0.12-0.19],ELOVL7,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,5:60842132
rs73038319-A,6e-13,-,0.9592,-,0.1693 unit decrease,[0.12-0.22],TBC1D5,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:18320267
rs11950533-A,7e-9,-,0.102,-,0.0916 unit decrease,[0.061-0.123],"C5orf24,TXNDC15",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,5:134863415
rs55961674-T,1e-11,-,0.1722,-,0.0861 unit increase,[0.061-0.111],KPNA1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:122478045
rs11707416-A,1e-10,-,0.3672,-,0.0627 unit decrease,[0.044-0.082],MED12L,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:151391177
rs9261484-T,2e-8,-,0.2451,-,0.0635 unit decrease,[0.042-0.085],TRIM40,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:30140906
rs10513789-T,1e-34,-,0.8112,-,0.1485 unit increase,[0.12-0.17],MCCC1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:183042285
rs873786-T,2e-21,-,0.0988,-,0.1731 unit decrease,[0.14-0.21],GAK,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:931588
rs12528068-T,2e-10,-,0.2844,-,0.0657 unit increase,[0.046-0.086],"RNU4-66P,RIMS1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:71778059
rs4698412-A,2.0000000000000002e-28,-,0.5529,-,0.1035 unit increase,[0.085-0.122],BST1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:15735725
rs34025766-A,3e-10,-,0.1589,-,0.0839 unit decrease,[0.058-0.11],LCORL,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:17967188
rs75859381-T,1e-10,-,0.9673,-,0.2207 unit decrease,[0.15-0.29],"HMGB1P13,LINC00326",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:132889222
rs199351-A,4.9999999999999996e-26,-,0.5939,-,0.1016 unit increase,[0.083-0.12],GPNMB,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,7:23260430
rs76949143-A,1e-8,-,0.0507,-,0.1432 unit decrease,[0.094-0.193],RABGEF1P1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,7:66544864
rs1293298-A,4e-16,-,0.7444,-,0.093 unit increase,[0.071-0.115],CTSB,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,8:11854934
rs620513-T,3e-15,-,0.2682,-,0.0856 unit decrease,[0.064-0.107],"MSR1,RN7SL474P",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,8:16840084
rs2280104-T,1e-8,-,0.3604,-,0.0556 unit increase,[0.036-0.075],BIN3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,8:22668467
rs2086641-T,2e-8,-,0.7225,-,0.0605 unit decrease,[0.04-0.081],CYRIB,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,8:129889663
rs13294100-T,9e-18,-,0.3422,-,0.0859 unit decrease,[0.066-0.106],SH3GL2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,9:17579692
rs10756907-A,5e-17,-,0.7666,-,0.0926 unit decrease,[0.071-0.114],SH3GL2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,9:17727067
rs6476434-T,7e-9,-,0.7336,-,0.0615 unit decrease,[0.041-0.082],UBAP2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,9:34046393
rs6825004-C,1e-9,-,0.6912,-,0.0622 unit increase,[0.042-0.082],SCARB2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:76189212
rs4101061-A,5e-19,-,0.7107,-,0.0912 unit decrease,[0.071-0.111],"FAM47E,SCARB2",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:76226816
rs6854006-T,6e-21,-,0.3632,-,0.0912 unit decrease,[0.072-0.11],"FAM47E-STBD1,FAM47E",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:76276901
rs356182-A,3.999999999999999e-154,-,0.6278,-,0.2774 unit decrease,[0.26-0.3],SNCA,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:89704960
rs5019538-A,1e-36,-,0.6792,-,0.1565 unit decrease,[0.13-0.18],SNCA,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:89715479
rs10797576-T,7e-17,-,0.1403,-,0.1114 unit increase,[0.085-0.137],SIPA1L2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:232528865
rs76116224-A,1e-8,-,0.9042,-,0.1104 unit increase,[0.072-0.148],KCNS3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:17966582
rs62333164-A,2e-10,-,0.3264,-,0.0638 unit decrease,[0.044-0.083],CLCN3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:169662006
rs57891859-A,5e-14,-,0.7185,-,0.0807 unit increase,[0.06-0.102],TMEM163,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:134707046
rs1474055-T,2.9999999999999996e-39,-,0.1312,-,0.1796 unit increase,[0.15-0.21],"STK39,RN7SL813P",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:168253884
rs26431-C,2e-9,-,0.7025,-,0.0621 unit increase,[0.042-0.082],PAM,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,5:103030090
rs6808178-T,8e-12,-,0.3794,-,0.0658 unit increase,[0.047-0.085],RBMS3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:28664199
rs12497850-T,1e-10,-,0.6476,-,0.0636 unit increase,[0.044-0.083],IP6K2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:48711556
rs4140646-A,6e-12,-,0.2081,-,0.0833 unit increase,[0.06-0.107],"GPR89P,RSL24D1P1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:27771022
rs1450522-A,5e-10,-,0.6742,-,0.0616 unit decrease,[0.042-0.081],SPTSSB,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,3:161359842
rs112485576-A,7e-28,-,0.163,-,0.1676 unit decrease,[0.14-0.2],"HLA-DQA1,HLA-DRB1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:32610995
rs34311866-T,1e-69,-,0.8065,-,0.2126 unit decrease,[0.19-0.24],TMEM175,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:958159
rs997368-A,2e-9,-,0.8049,-,0.0714 unit increase,[0.048-0.095],"LINC02527,CCN6",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:111922088
rs12600861-A,1e-8,-,0.6484,-,0.0565 unit decrease,[0.037-0.076],CHRNB1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:7452302
rs12951632-T,1e-9,-,0.7349,-,0.0642 unit increase,[0.043-0.085],RETREG3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:42588995
rs2269906-A,6e-10,-,0.6531,-,0.0631 unit increase,[0.043-0.083],"UBTF,ATXN7L3-AS1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:44216969
rs850738-A,1e-11,-,0.6056,-,0.071 unit decrease,[0.05-0.092],FAM171A2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:44357262
rs62053943-T,3.9999999999999994e-68,-,0.1552,-,0.27 unit decrease,[0.24-0.3],LINC02210-CRHR1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:45666837
rs117615688-A,7e-16,-,0.067,-,0.2324 unit decrease,[0.18-0.29],LINC02210-CRHR1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:45720942
rs11658976-A,4e-8,-,0.5802,-,0.0624 unit decrease,[0.04-0.085],WNT3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:46789439
rs61169879-T,9e-10,-,0.1641,-,0.082 unit increase,[0.056-0.108],BRIP1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:61840005
rs666463-A,3e-9,-,0.8328,-,0.076 unit increase,[0.051-0.101],DNAH17,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:78429399
rs1941685-T,2e-8,-,0.4983,-,0.0531 unit increase,[0.035-0.072],ASXL3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,18:33724354
rs12456492-A,4.0000000000000004e-23,-,0.6816,-,0.0983 unit decrease,[0.079-0.118],RIT2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,18:43093415
rs8087969-T,1e-8,-,0.5496,-,0.0578 unit decrease,[0.038-0.078],"SMAD4,SRSF10P1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,18:51157219
rs55818311-T,4e-10,-,0.6937,-,0.0696 unit decrease,[0.048-0.091],SPPL2B,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,19:2341049
rs77351827-T,9e-9,-,0.1275,-,0.0802 unit increase,[0.053-0.107],CRLS1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,20:6025395
rs2248244-A,3e-11,-,0.2828,-,0.0714 unit increase,[0.05-0.092],DYRK1A,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,21:37480059
rs35643925-A,8e-22,-,0.0195,-,0.389 unit increase,[0.31-0.47],"SEMA4A,SLC25A44",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,1:156185069
rs4954162-A,2e-8,-,0.1642,-,0.0746 unit decrease,[0.049-0.1],TMEM163,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,2:134681219
rs356228-C,1e-48,-,0.4589,-,0.1503 unit increase,[0.13-0.17],"SNCA,GPRIN3",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:89685975
rs356203-T,5e-149,-,0.6149,-,0.2504 unit decrease,[0.23-0.27],SNCA,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,4:89744890
rs6875262-T,1e-8,-,0.0986,-,0.1141 unit increase,[0.075-0.153],"LINC02240,ZNF608",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,5:124774580
rs9267659-A,4e-11,-,0.2004,-,0.079 unit increase,[0.056-0.102],"EHMT2-AS1,SLC44A4",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,6:31878457
rs181609621-A,8e-11,-,0.9882,-,0.4232 unit decrease,[0.3-0.55],"FGD4,DNM1L",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:32657825
rs117073808-T,2e-20,-,0.9809,-,0.3955 unit decrease,[0.31-0.48],MUC19,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:40528770
rs141128804-T,6e-14,-,0.0173,-,0.3468 unit increase,[0.26-0.44],MUC19,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:40542837
rs138017112-C,7e-12,-,0.0142,-,0.413 unit increase,[0.29-0.53],"GXYLT1,LINC02400",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:41901977
rs896435-T,3e-13,-,0.6892,-,0.0735 unit increase,[0.054-0.093],ITGA8,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,10:15515407
rs10748818-A,1e-9,-,0.8514,-,0.079 unit decrease,[0.054-0.104],GBF1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,10:102255522
rs72840788-A,2e-11,-,0.2155,-,0.0763 unit increase,[0.054-0.098],BAG3,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,10:119656173
rs117896735-A,2.0000000000000002e-28,-,0.0166,-,0.4354 unit increase,[0.36-0.51],INPP5F,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,10:119776815
rs7938782-A,2e-9,-,0.8776,-,0.087 unit increase,[0.059-0.115],RNF141,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,11:10537230
rs12283611-A,3e-10,-,0.4148,-,0.0645 unit decrease,[0.045-0.084],DLG2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,11:83776234
rs3802920-T,6e-20,-,0.2054,-,0.1073 unit increase,[0.084-0.13],IGSF9B,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,11:133917106
rs76904798-T,2.0000000000000002e-28,-,0.1444,-,0.1439 unit increase,[0.12-0.17],"LRRK2-DT,LRRK2",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:40220632
rs34637584-A,4e-148,-,0.0015,-,2.4289 unit increase,[2.25-2.61],LRRK2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:40340400
rs7134559-T,4e-8,-,0.404,-,0.0539 unit decrease,[0.035-0.073],"RPL13AP21,SLC38A1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:46025303
rs10847864-T,9.999999999999999e-38,-,0.364,-,0.1478 unit increase,[0.13-0.17],HIP1R,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:122842051
rs11610045-A,2e-10,-,0.4896,-,0.0601 unit increase,[0.042-0.079],"FBRSL1,GALNT9",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:132487182
rs9568188-T,1e-8,-,0.7397,-,0.0617 unit increase,[0.041-0.083],CAB39L,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,13:49353596
rs4771268-T,1e-9,-,0.2295,-,0.0675 unit increase,[0.046-0.089],"MBNL2,LINC00456",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,13:97212767
rs12147950-T,4e-8,-,0.4376,-,0.0529 unit decrease,[0.034-0.072],MIPOL1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,14:37520065
rs11158026-T,2e-16,-,0.3245,-,0.0842 unit decrease,[0.064-0.104],GCH1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,14:54882151
rs3742785-A,2e-9,-,0.7866,-,0.0707 unit increase,[0.048-0.094],RPS6KL1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,14:74906331
rs979812-T,6e-11,-,0.4421,-,0.061 unit increase,[0.043-0.079],"RNU6-835P,GPR65",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,14:87997920
rs2251086-T,6e-18,-,0.1417,-,0.1186 unit decrease,[0.092-0.145],"RORA,LINC02349",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,15:61705186
rs6497339-A,3e-11,-,0.4536,-,0.063 unit increase,[0.044-0.082],SYT17,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:19266171
rs2904880-C,8e-10,-,0.3094,-,0.065 unit decrease,[0.044-0.086],"CD19,RABEP2",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:28933075
rs11150601-A,5e-20,-,0.6442,-,0.0907 unit increase,[0.071-0.11],SETD1A,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:30966478
rs6500328-A,2e-9,-,0.5985,-,0.0586 unit increase,[0.04-0.078],NOD2,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:50702745
rs3104783-A,1e-12,-,0.4343,-,0.0668 unit increase,[0.048-0.085],CASC16,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:52602330
rs10221156-A,1e-10,-,0.0932,-,0.1156 unit decrease,[0.081-0.151],PHB1P21,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,16:52935514
rs144755950-T,2e-10,-,0.9856,-,0.3993 unit decrease,[0.28-0.52],GXYLT1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,12:42141601
rs17686238-T,8e-27,-,0.1071,-,0.1896 unit decrease,[0.15-0.22],"ARHGAP27,RNA5SP443",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:45339907
rs9912362-T,2e-13,-,0.3594,-,0.077 unit increase,[0.057-0.097],LINC02210-CRHR1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:45706862
rs7221167-T,9.999999999999999e-38,-,0.581,-,0.1443 unit increase,[0.12-0.17],MAPT-AS1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:45855941
rs7225002-A,2e-40,-,0.6094,-,0.1351 unit increase,[0.12-0.15],KANSL1,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:46111701
rs199453-T,9e-67,-,0.231,-,0.2045 unit decrease,[0.18-0.23],NSF,Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,17:46723580
rs2295545-T,8e-11,-,0.6105,-,0.0622 unit increase,[0.043-0.081],"LZTS3,DDRGK1",Parkinson's disease or first degree relation to individual with Parkinson's disease,Parkinson disease,-,GCST009325,20:3184040
rs6826785-?,1.9999999999999997e-37,-,NR,-,-,-,SNCA,Parkinson's disease,Parkinson disease,-,GCST010049,4:89761323
rs6679073-?,4e-21,-,NR,-,-,-,"SLC41A1,RAB29",Parkinson's disease,Parkinson disease,-,GCST010049,1:205787356
rs2292056-?,8e-17,-,NR,-,-,-,"MCCC1,MCCC1-AS1",Parkinson's disease,Parkinson disease,-,GCST010049,3:183017423
rs16846351-?,8e-10,-,NR,-,-,-,"ITPKB-IT1,ITPKB",Parkinson's disease,Parkinson disease,-,GCST010049,1:226659011
rs12278023-?,2e-8,-,NR,-,-,-,DLG2,Parkinson's disease,Parkinson disease,-,GCST010049,11:83799074
rs1887316-?,3e-8,-,NR,-,-,-,FYN,Parkinson's disease,Parkinson disease,-,GCST010049,6:111830249
rs4130047-?,5e-8,-,NR,-,-,-,RIT2,Parkinson's disease,Parkinson disease,-,GCST010049,18:43098270
rs6449168-?,4e-7,-,NR,-,-,-,BST1,Parkinson's disease,Parkinson disease,-,GCST010049,4:15726090
rs34311866-?,7e-6,-,NR,-,-,-,TMEM175,Parkinson's disease,Parkinson disease,-,GCST010049,4:958159
rs246814-C,6e-10,-,NR,1.11,-,[1.07-1.13],"SV2C,SV2C-AS2",Parkinson's disease,Parkinson disease,-,GCST010049,5:76303383
rs3115534-G,2e-14,-,NR,1.58,-,[1.37-1.8],GBA1,Parkinson's disease,Parkinson disease,-,GCST90320242,1:155235878
rs35643925-A,5e-9,-,NR,-,0.5105 unit increase,[0.34-0.68],"SEMA4A,SLC25A44",Parkinson's disease,Parkinson disease,-,GCST90018894,1:156185069
rs356220-C,6e-13,-,NR,-,0.2542 unit decrease,[0.19-0.32],SNCA,Parkinson's disease,Parkinson disease,-,GCST90018894,4:89720189
rs12771445-T,1e-8,-,0.314,0.663,-,[0.52-0.8],PLPP4,Parkinson's disease,Parkinson disease,-,GCST90095083,10:120558635
rs356182-A,6e-8,-,0.617,0.686,-,[0.55-0.82],SNCA,Parkinson's disease,Parkinson disease,-,GCST90095083,4:89704960
rs7752646-T,4e-7,-,0.873,0.489,-,[0.28-0.7],"FAM136FP,NUP50P4",Parkinson's disease,Parkinson disease,-,GCST90095083,6:74737372
rs356219-?,6e-41,-,NR,-,-,-,SNCA,Parkinson disease (MTAG),Parkinson disease,-,GCST90256604,4:89716450
rs1372518-?,3e-28,-,NR,-,-,-,SNCA,Parkinson disease (MTAG),Parkinson disease,-,GCST90256604,4:89836143
rs373616374-?,6e-9,-,NR,-,-,-,BCL9,Parkinson's disease (PheCode 332),Parkinson disease,-,GCST90651411,1:147564992
chr17:43755871-A,7e-13,-,0.2564,-,0.132 unit decrease,[0.096-0.168],-,Parkinson's disease,Parkinson disease,-,GCST90475830,-
rs34637584-G,2e-11,-,0.9997,-,1.638 unit decrease,[1.25-2.03],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90475830,12:40340400
rs356183-G,3e-12,-,0.4541,-,0.112 unit increase,[0.08-0.144],SNCA,Parkinson's disease,Parkinson disease,-,GCST90475830,4:89704947
rs1311506805-A,4e-11,-,0.9996,-,3.35 unit decrease,[3.33-3.37],SPATA6,Parkinson's disease,Parkinson disease,-,GCST90480008,1:48345118
rs356183-G,6e-13,-,0.4991,-,0.1157 unit increase,[0.081-0.151],SNCA,Parkinson's disease,Parkinson disease,-,GCST90480008,4:89704947
rs34637584-G,7e-17,-,0.9996,-,1.594 unit decrease,[1.53-1.66],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90480008,12:40340400
rs1724407-C,2e-13,-,0.3076,-,0.1293 unit decrease,[0.1-0.159],LINC02210-CRHR1,Parkinson's disease,Parkinson disease,-,GCST90480008,17:45670249
rs528521148-C,1e-11,-,0.9968,-,0.9932 unit decrease,[0.9-1.09],COMMD1,Parkinson's disease,Parkinson disease,-,GCST90479727,2:62072723
rs559557961-C,3e-11,-,0.9995,-,3.021 unit decrease,[2.99-3.05],"LINC02034,TPRA1",Parkinson's disease,Parkinson disease,-,GCST90479727,3:127563982
rs34637584-G,3e-12,-,0.9996,-,1.805 unit decrease,[1.74-1.87],LRRK2,Parkinson's disease,Parkinson disease,-,GCST90479727,12:40340400
rs34400130-C,4e-11,-,0.9991,-,3.784 unit decrease,[3.77-3.8],CDC42BPB,Parkinson's disease,Parkinson disease,-,GCST90479727,14:102973017
rs73415968-G,2e-11,-,0.9994,-,3.095 unit decrease,[3.07-3.12],LDLRAD4,Parkinson's disease,Parkinson disease,-,GCST90479727,18:13651014
rs1941184-C,4e-6,-,NR,-,2.28 years decrease,[NR],DSG3,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST000490,18:31458160
rs17565841-A,3e-6,-,NR,-,2.84 years decrease,[NR],"GABRG3,OCA2",Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST000490,15:27752101
rs10918270-A,8e-6,-,NR,-,2.26 years decrease,[NR],ATF6,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST000490,1:161945711
rs10767971-T,5e-7,-,NR,-,3.24 years increase,[NR],"QSER1,PRRG4",Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST000490,11:32874118
rs7577851-T,9e-6,-,NR,-,6.85 years decrease,[NR],AAK1,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST000490,2:69496578
rs997277-?,5e-8,-,0.345,1.63,-,[NR],"COL3A1,DIRC1",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,2:188886137
rs10788972-?,6e-8,-,0.435,1.56,-,[NR],TCEANC2,Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,1:54106570
rs78736162-?,3e-7,-,0.042,2.79,-,[NR],MX2,Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,21:41368561
rs6465122-T,7e-7,-,0.223,1.67,-,[NR],ZP3,Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,7:76411547
rs12921479-?,9e-7,-,0.343,1.54,-,[NR],"TRAPPC2L,PABPN1L",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,16:88862799
rs141863958-?,1e-6,-,0.028,3.32,-,[NR],KCNIP4,Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,4:21291814
rs816535-C,1e-6,-,0.811,1.8,-,[NR],"MIR663AHG,FRG1CP",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,20:26275360
rs7984966-?,2e-6,-,0.245,1.61,-,[NR],"HTR2A-AS1,HTR2A",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,13:46855311
rs4778720-?,2e-6,-,0.442,1.46,-,[NR],"RNU6-667P,RPL7L1P15",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,15:79683305
rs12959200-?,2e-6,-,0.141,1.68,-,[NR],"LINC02582,RN7SL401P",Parkinson disease and lewy body pathology,"Lewy body attribute,Parkinson disease",-,GCST002778,18:73599819
rs344650-G,1e-11,-,0.016,3.4,-,[2.39-4.85],LHFPL2,"Parkinson's disease (familial, age at onset)","age at onset,Parkinson disease",-,GCST003652,5:78564785
rs74335301-?,3e-6,-,NR,2.2,-,[NR],TRPS1,"Parkinson's disease (familial, age at onset)","age at onset,Parkinson disease",-,GCST003652,8:115626410
rs79503702-?,5e-8,-,NR,3.82,-,[NR],KLHDC1,"Parkinson's disease (familial, age at onset)","age at onset,Parkinson disease",-,GCST003652,14:49739452
rs117267308-A,9e-11,-,0.012,4.55,-,[2.88-7.20],TPM1,"Parkinson's disease (familial, age at onset)","age at onset,Parkinson disease",-,GCST003652,15:63054177
rs5870994-C,1e-6,-,0.23,-,0.21 unit increase,[0.13-0.29],"ZNF475,SNCAIP",Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,5:122193659
rs7870456-T,2e-6,-,0.22,-,0.21 unit increase,[0.13-0.29],PTPRD,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,9:8454921
rs72767442-A,2e-6,-,0.41,-,0.18 unit decrease,[0.1-0.26],MCTP2,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,15:94320087
rs6741991-G,3e-6,-,0.26,-,0.2 unit increase,[0.12-0.28],KLHL29,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,2:23493673
rs35950207-T,5e-6,-,0.31,-,0.18 unit decrease,[0.1-0.26],"AQP10,RNU6-121P",Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,1:154319482
chr6:119067987-T,5e-6,-,NR,-,0.7 unit increase,[0.41-0.99],-,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,-
rs74709761-C,6e-6,-,NR,-,0.41 unit decrease,[0.23-0.59],ANO2,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,12:5829410
rs4436579-T,7e-6,-,NR,-,0.18 unit increase,[0.1-0.26],"NXPE2,CADM1",Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,11:114821560
rs12813102-C,8e-6,-,0.04,-,0.43 unit increase,[0.23-0.63],GPR19,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,12:12677103
rs4128840-A,8e-6,-,0.41,-,0.17 unit decrease,[0.092-0.248],THSD4,Parkinson's disease progression (motor),"Parkinson disease,disease progression measurement",-,GCST011038,15:71520619
rs429358-C,3e-13,-,0.14,-,0.38 unit decrease,[0.28-0.48],APOE,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,19:44908684
rs143371462-G,7e-7,-,0.02,-,0.64 unit decrease,[0.39-0.89],SLCO1B3,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,12:20812884
rs113730632-G,2e-6,-,0.05,-,0.41 unit increase,[0.23-0.59],NR1D2,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,3:23951314
rs34105455-G,4e-6,-,0.13,-,0.25 unit decrease,[0.15-0.35],DENND2B,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,11:8882396
rs2956605-A,4e-6,-,NR,-,0.17 unit decrease,[0.092-0.248],"CRISPLD1,PI15",Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,8:74970819
rs5755468-C,4e-6,-,NR,-,0.17 unit decrease,[0.092-0.248],LINC02885,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,22:34970241
rs148603475-T,6e-6,-,NR,-,0.31 unit decrease,[0.17-0.45],"SLC28A3,NTRK2",Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,9:84627637
rs1124933-A,8e-6,-,NR,-,0.16 unit decrease,[0.082-0.238],"Y_RNA,RNU7-137P",Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,20:18097908
rs6488987-C,2e-6,-,0.36,-,0.18 unit increase,[0.10-0.26],AACS,Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,12:125083207
rs17092224-C,4e-6,-,0.11,-,0.27 unit decrease,[0.15-0.39],"ASS1P13,GUCY1A2",Parkinson's disease progression (cognitive),"Parkinson disease,disease progression measurement",-,GCST011037,11:107127349
rs429358-C,1e-8,-,0.14,-,0.35 unit increase,[0.23-0.47],APOE,Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,19:44908684
rs224750-T,1e-6,-,0.37,-,0.21 unit decrease,[0.13-0.29],"LINC02629,PARD3",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,10:33942102
rs11634227-C,1e-6,-,0.41,-,0.21 unit decrease,[0.13-0.29],MCTP2,Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,15:94318611
rs79987229-T,3e-6,-,0.01,-,0.85 unit increase,[0.50-1.20],FAM184A,Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,6:119112570
rs62343939-T,3e-6,-,0.05,-,0.43 unit increase,[0.25-0.61],"LINC02063,LINC02114",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,5:4699328
rs10253857-T,4e-6,-,0.22,-,0.23 unit decrease,[0.13-0.33],"LINC02889,SNX13",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,7:17673826
rs13424530-A,4e-6,-,0.44,-,0.2 unit increase,[0.12-0.28],SULT1C2,Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,2:108292945
rs4802739-C,1e-6,-,0.40,-,0.2 unit increase,[0.12-0.28],"GPR32,GPR32P1",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,19:50760039
rs17554587-C,3e-6,-,0.22,-,0.85 unit increase,[0.50-1.20],"MTND5P40,SQOR",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,15:45744252
rs17367669-T,3e-6,-,0.22,-,0.23 unit increase,[0.13-0.33],"ZNF475,SNCAIP",Parkinson's disease progression (composite),"Parkinson disease,disease progression measurement",-,GCST011039,5:122191027
rs73656147-?,9e-9,-,NR,-,4.08 years decrease,[0.70-7.45],PLPPR1,Parkinson's disease (age at diagnosis),"age at diagnosis,Parkinson disease",-,GCST007198,9:101115169
rs6593808-?,1e-10,-,NR,-,0.28 unit decrease,[0.2-0.36],"RN7SL261P,GJA5",Parkinson disease axial motor progression,"Parkinson disease,disease progression measurement",-,GCST90321081,1:147747118
rs4073509-?,2e-7,-,NR,-,0.52 unit increase,[0.32-0.72],"CAVIN2,NABP1",Parkinson disease axial motor progression,"Parkinson disease,disease progression measurement",-,GCST90321081,2:191746287
rs117239007-?,5e-7,-,NR,-,0.68 unit increase,[0.41-0.95],"LINC00544,LINC00365",Parkinson disease axial motor progression,"Parkinson disease,disease progression measurement",-,GCST90321081,13:29975879
rs67383717-?,2e-6,-,NR,-,-,-,ERCC6L2-AS1,Parkinson's disease (pesticide exposure interaction),"pesticide exposure measurement,Parkinson disease",-,GCST003600,9:95864266
rs356203-T,2e-7,-,0.6226,-,1.4337 unit increase,[0.89-1.98],SNCA,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST009513,4:89744890
rs9356013-?,4e-13,-,NR,-,4.11 unit decrease,[3.01-5.21],PRKN,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST009513,6:162403694
rs9783733-?,3e-9,-,NR,-,2.3 unit increase,[1.54-3.06],PWRN4,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST011677,15:23923803
rs3775458-?,1e-6,-,NR,-,1.41 unit decrease,[0.84-1.98],SNCA,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST011677,4:89818097
rs356203-?,2e-12,-,NR,-,0.626 unit decrease,[0.45-0.80],SNCA,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST007780,4:89744890
rs983361-?,7e-6,(Conditional),NR,-,0.484 unit decrease,[0.27-0.70],SNCA-AS1,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST007780,4:89840793
rs34311866-C,1e-8,-,0.2566,-,0.613 unit decrease,[0.40-0.82],TMEM175,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST007780,4:958159
rs429358-?,6e-8,-,NR,-,0.707 unit decrease,[0.45-0.96],APOE,Parkinson's disease (age of onset),"age at onset,Parkinson disease",-,GCST007780,19:44908684
rs368657122-G,9e-12,-,0.9983,-,1.633 unit decrease,[1.56-1.71],"H2ACP1,SERTM1",Takes medication for parkinson's disease?,"drug use measurement,Parkinson disease",-,GCST90479726,13:36532864
rs145533835-T,1e-11,-,0.9955,-,1.633 unit decrease,[1.56-1.71],"RNU6-259P,RNA5SP102",Takes medication for parkinson's disease?,"drug use measurement,Parkinson disease",-,GCST90479726,2:124952741
rs189775425-C,1e-12,-,0.999,-,2.877 unit decrease,[2.85-2.91],"RPL7AP56,IFTAP",Takes medication for parkinson's disease?,"drug use measurement,Parkinson disease",-,GCST90479726,11:37312016
rs429358-C,2e-15,-,NR,2.41,-,[1.94-3.0],APOE,Parkinson’s disease progression to dementia,"dementia,Parkinson disease,disease progression measurement",-,GCST90270129,19:44908684
rs80306347-C,7e-9,-,NR,3.23,-,[2.17-4.81],LRP1B,Parkinson’s disease progression to dementia,"dementia,Parkinson disease,disease progression measurement",-,GCST90270129,2:141242702
rs78294974-A,4e-8,-,NR,3.9,-,[2.4-6.32],BBS9,Parkinson’s disease progression to dementia,"dementia,Parkinson disease,disease progression measurement",-,GCST90270129,7:33144410
